Profil

Beguin Yves

Département des sciences cliniques

See author's contact details
ORCID
0000-0003-4650-7520
Main Referenced Co-authors
Baron, Frédéric  (228)
Fillet, Georges  (130)
Caers, Jo  (82)
Hannon, Muriel  (78)
Briquet, Alexandra  (63)
Main Referenced Keywords
Humans (206); Male (102); Female (91); Adult (85); Middle Aged (84);
Main Referenced Unit & Research Centers
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège [BE] (27)
Giga-Infection, Immunity and Inflammation Laboratoire d'hématologie (7)
CEIB - Centre Interfacultaire des Biomatériaux - ULiège [BE] (3)
GIGA I3-Hematology - ULiège [BE] (1)
Giga-Haematology (1)
Main Referenced Disciplines
Hematology (565)
Biochemistry, biophysics & molecular biology (29)
Immunology & infectious disease (27)
Surgery (25)
Gastroenterology & hepatology (14)

Publications (total 670)

The most downloaded
10869 downloads
Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176. https://hdl.handle.net/2268/80188

The most cited

525 citations (Scopus®)

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999). Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 94 (2), 429-33. doi:10.1182/blood.v94.2.429.414k26_429_433 https://hdl.handle.net/2268/9444

Book chapters or contributions to a collective book as author or co-author

GREGOIRE, C., Louis, E., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., GIET, O., Beguin, Y., & BARON, F. (2017). The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 730-753). Hoboken, United States: John Wiley & Sons, Inc.
Peer reviewed

GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc.
Peer reviewed

Beguin, Y., & Vanstraelen, G. (2008). Prediction of response to recombinant human erythropoietin in the anemia of cancer. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (2nd Ed.). Berlin - Heidelberg, Germany: Springer-Verlag.

Vanstraelen, G., & Beguin, Y. (2008). rhEPO in hematopoietic stem cell transplantation. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (2nd Ed.) (pp. 583-614). Berlin - Heidelberg, Germany: Springer-Verla.

Beguin, Y., & Estatiev, R. (2008). Iron deficiency. In C. Gasche, Anemia in inflammatory bowel disease (pp. 42-47). Uni-Med Verlag.

Beguin, Y. (2008). Erythropoiesis. In C. Gasche, Anemia in inflammatory bowel disease (pp. 38-42). Uni-Med Verlag.

Beguin, Y., Dujardin, C., Piron, M., & Vanstraelen, G. (2006). Treatment of anaemia with erythropoietin. In C. Brugnara & C. Beaumont, ESH Scientific Updates. Disorders of Iron Homeostasis, Erythrocytes and erythropoiesis (pp. 180-209). Elsevier Science.

Beguin, Y. (2005). Endogenous erythropoietin in the anemia of chronic disorders. In W. Weiss, V. R. Gordeuk, ... C. Hershko, Anemia of chronic disease (pp. 145-200). New York, United States - New York: Marcel Dekker.

Beguin, Y. (2005). Erythropoietic agents and iron. In M. Aapro, C. Bokemeyer, ... H. Ludwig, ESO Scientific Updates, Vol. 6 (2nd ed). Anaemia in cancer (pp. 199-220). Elsevier Science.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Whole-Body Positron Emission Tomography using 18F-Fluorodeoxyglucose for Staging Response Assessment in Hodgkin's Disease. In B. C. Heinz (Ed.), Trends in Hodgkin's Disease Research (pp. 169-188). New York, United States: Nova Science Publishers.

Beguin, Y. (2002). Predictive factors for response of anemia to recombinant human erythropoietin. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (pp. 263-286). Berlin - Heidelberg, Germany: Springer-Verlag.

Beguin, Y. (2001). Prediction of response to rHuEpo. In C. Bokemeyer & H. Ludwig, ESO Scientific Upadtes, Vol. 6 Anaemia in cancer (pp. 153-165). Elsevier Science.

Clement, J., De Bock, R., & Beguin, Y. (1994). Defective Epo production contributes to anemia persistent after ARF in nephropathia epidemica (NE). In Papadimitriou & Alexopoulos, Proceedings of the 3rd International Satellite Symposium on Acute Renal Failure (pp. 467-473). Thessaloniki, Greece: University Studio Press.

Baudoux, E., Janssens, M., Beguin, Y., Sondag, D., Fillet, G., & Lamy, M. (1993). Erythropoietin in surgery. In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion (pp. 213-217).

Fillet, G., & Beguin, Y. (1992). Iron availability for erythropoiesis. In C. Drewienkiewicz, The potential use of erythropoietin to diminish the need for homologous blood in surgery (pp. 43-49). Medical Action Communication.

Beguin, Y., Huebers, H., Finch, C. A., Weber, G., & Roelandts, I. (1988). The regulation of liver iron metabolism. In P. Bratter & P. Schramel, Trace element analytical chemistry in medicine and biology, Vol. 5 (pp. 542-547). Walter de Gruyter.

Beguin, Y., Weber, G., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., & Fillet, G. (1987). Dosage du zinc sérique chez des patients atteints de leucémie aiguë. In A. Favier, J. Arnaud, ... H. Faure, Le zinc en médecine et biologie (pp. 224-226). Paris, France: Editions Médicales Internationales.

Beguin, Y., Detroz, B., Defraigne, J.-O., Bury, J., Boniver, J., Fillet, G., & Lejeune, G. (1985). Solitary plasmacytoma of the thyroid with serum monoclonal IgG. In J. Radl, W. Hijmans, ... B. Van Camp, Monoclonal gammopathies. Clinical significance and basic mechanisms (pp. 251-253). Eurage.

Beguin, Y., Delbrouck, J.-M., Roelandts, I., & Weber, G. (1984). Serum trace elements in hemoproliferative diseases. In P. Bratter & P. Schramel, Trace element analytical chemistry in medicine and biology, Vol. 3 (pp. 383-389). Walter de Gruyter.

Articles accepted in reviewed journal

Bayoudh, F., Giot, J.-B., Descy, J., Fontaine, C., Hayette, M.-P., Baron, F., WILLEMS, E., Beguin, Y., FRIPPIAT, F., & Servais, S. (March 2024). Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 72 (1), 103422. doi:10.1016/j.retram.2023.103422
Peer Reviewed verified by ORBi

Lombardo, G., HAFRAOUI, K., Beguin, Y., & VERTENOEIL, G. (February 2024). Comment j’explore … une polyglobulie. Revue Médicale de Liège, 79 (2), 110 - 115.
Editorial Reviewed verified by ORBi

Ortí, G., Gras, L., Koster, L., Kulagin, A., Byrne, J., Apperley, J. F., Halaburda, K., Blau, I. W., Clark, A., Kröger, N., Griskevicius, L., Carlson, K., Collin, M., Bloor, A., Raiola, A. M., Blaise, D., Aljurf, M., López-Corral, L., Sakellari, I., ... Yakoub-Agha, I. (2024). Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT). Transplantation and Cellular Therapy, 30, 93.e1 - 93.e12. doi:10.1016/j.jtct.2023.09.019
Peer Reviewed verified by ORBi

Conrad, A., Beguin, Y., Guenounou, S., Le Bourgeois, A., Ménard, A.-L., Rialland, F., Layal, S., Mamez, A.-C., Yakoub-Agha, I., & El Cheikh, J. (2024). Mise à jour du calendrier vaccinal après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 111 (25), 40-S49. doi:10.1016/j.bulcan.2023.05.007
Peer Reviewed verified by ORBi

Lacan, C., Lambert, J., Forcade, E., Robin, M., Chevallier, P., Loron, S., Bulabois, C.-É., Orvain, C., Ceballos, P., Daguindau, E., Charbonnier, A., Chalandon, Y., Bernard, M., Simand, C., Rubio, M.-T., Turlure, P., Maertens, J., Huynh, A., Loschi, M., ... Nguyen, S. (2024). Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry. Journal of Hematology and Oncology, 17, 2. doi:10.1186/s13045-023-01515-4
Peer Reviewed verified by ORBi

Robin, M., Gras, L., Koster, L., Gagelmann, N., van Gorkom, G., Ederr, M., Itälä-Remes, M., Zuckerman, T., Beguin, Y., Schaap, N., Drozd-Sokolowska, J., Raj, K., Hayden, P. J., de Wreede, L. C., Battipaglia, G., Polverelli, N., Czerw, T., Hernandez Boluda, J. C., Kröger, N., ... McLornan, D. P. (2024). Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT. British Journal of Haematology, 204, 715 - 718. doi:10.1111/bjh.19214
Peer Reviewed verified by ORBi

Voisot, A., Triffaux, F., Roland, I., Meex, C., Detrembleur, N., Baron, F., WILLEMS, E., WALTREGNY, D., Beguin, Y., & Servais, S. (22 September 2023). Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 71 (1), 103366. doi:10.1016/j.retram.2022.103366
Peer Reviewed verified by ORBi

COVID-19 Host Genetics Initiative, Rahmouni, S., Georges, M., Moutschen, M., Darcis, G., & Beguin, Y. (September 2023). A second update on mapping the human genetic architecture of COVID-19. Nature, 621 (7977), 7 - E26. doi:10.1038/s41586-023-06355-3
Peer Reviewed verified by ORBi

Ritacco, C., Köse, M. C., Courtois, J., Canti, L., Beguin, C., DUBOIS, S., Vandenhove, B., Servais, S., Caers, J., Beguin, Y., Ehx, G.* , & Baron, F.*. (17 March 2023). Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells. iScience, 26 (3), 106085. doi:10.1016/j.isci.2023.106085
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113.
Editorial Reviewed verified by ORBi

Saccardi, R., Putter, H., Eikema, D., Busto, M., McGrath, E., Middelkoop, B., Adams, G., Atlija, M., Ayuk, A., Baldomero, H., Beguin, Y., del la Camara, R., Cedillo, A., Sureda, A., Chabannon, C., Corbacioglu, S., Dolstra, H., Duarte, R., Dulery, R., ... Snowden, J. (2023). Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation, 58, 659-666. doi:10.1038/s41409-023-01924-6
Peer Reviewed verified by ORBi

Servais, S., Baron, F., LECHANTEUR, C., Seidel, L., BAUDOUX, E., BRIQUET, A., Selleslag, D., Maertens, J., Poire, X., Schroyens, W., Graux, C., De Becker, A., Zachee, P., Ory, A., Herman, J., Kerre, T., & Beguin, Y. (2023). Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.1106464
Peer Reviewed verified by ORBi

Rey, G., Daguenet, E., Bonjean, P., Devillier, R., Fegueux, N., Forcade, E., Srour, M., Chevallier, P., Robin, M., Suarez, F., Micol, J.-B., Labussière-Wallet, H., Bilger, K., Daguindau, E., Bay, J.-O., Fayard, A., Bulabois, C.-E., Nguyen-Quoc, S., Genthon, A., ... Tavernier, E. (2023). Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC. Bone Marrow Transplantation, 58, 1331 - 1338. doi:10.1038/s41409-023-02082-5
Peer Reviewed verified by ORBi

Kaphan, E., Bettega, F., Forcade, E., Labussière-Wallet, H., Fegueux, N., Robin, M., Peffault De Latour, R., Huynh, A., Lapierre, L., Berceanu, A., Marcais, A., Debureaux, P.-E., Vanlangendonck, N., Bulabois, C.-E., Magro, L., Daniel, A., Galtier, J., Lioure, B., Chevallier, P., ... Thiebaut-Bertrand, A. (2023). Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC. Transplantation and Cellular Therapy, 362, 1 - e12. doi:10.1016/j.jtct.2023.02.020
Peer Reviewed verified by ORBi

Reenaers, C., GILLARD, R., Coimbra, C., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2023). Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study. Journal of Crohn's and Colitis, 17, 728-737. doi:10.1093/ecco-jcc/jjac192
Peer Reviewed verified by ORBi

Tournilhac, O., van Gelder, M., Eikema, D., van Biezen, A., Dreger, P., Bornhäuser, M., Vucinic, V., Scheid, C., Cornelissen, J., Schroeder, T., Jindra, P., Sengeloev, H., Nguyen, S., Stelljes, M., Blau, I., Mayer, J., Paneesha, S., Chevalier, C., Forcade, E., ... Yakoub-Agha, I. (2023). The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009-2019: a perspective from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 58, 621-624. doi:10.1038/s41409-023-01955-z
Peer Reviewed verified by ORBi

Chauvet, P., Paviglianiti, A., Labopin, M., Labussière, H., Boissel, N., Robin, M., Maillard, N., Ouachée-Chardin, M., Forcade, E., Poiré, X., Chantepie, S., Huynh, A., Bulabois, C., Leclerc, M., Maury, S., Chevallier, P., Cluzeau, T., Mear, J., Cornillon, J., ... Brissot, E. (2023). Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: A study of the SFGM-TC. Bone Marrow Transplantation, 58, 72-79. doi:10.1038/s41409-022-01846-9
Peer Reviewed verified by ORBi

Srour, M., Alsuliman, T., Labreuche, J., Bulabois, C., Chevalier, P., Daguindau, E., Forcade, E., François, S., Guillerm, G., Coiteux, V., Turlure, P., Beguin, Y., Yakoub-Agha, I., & Magro, L. (2023). Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease: A prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation, 58, 401-406. doi:10.1038/s41409-022-01898-x
Peer Reviewed verified by ORBi

El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435
Peer Reviewed verified by ORBi

Michel, C., Robin, M., Morisset, S., Blaise, D., Maertens, J., Chevalier, P., Castilla-Llorente, C., Forcade, E., Ceballos, P., Yakoug-Agha, I., Poire, X., Carre, M., Bay, J.-O., Beguin, Y., Loschi, M., Huynh, A., Guillerm, G., François, S., Mear, J.-B., ... D'Aveni, M. (2023). Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS. Bone Marrow Transplantation, 58, 534 - 543. doi:10.1038/s41409-023-01931-7
Peer Reviewed verified by ORBi

Schmitz, L., Pirotte, M., Lebeau, A., Ernst, M., Fillet, M., DEVEY, A., SCHMITT, J., Cobraiville, G., BINSFELD, M., Gofflot, S., Beguin, Y.* , & Vertenoeil, G.*. (2023). Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism. Therapeutic Advances in Hematology, 14, 20406207231199837. doi:10.1177/20406207231199837
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Lejeune, M., Köse, M. C., Jassin, M., Gou, M.-J., Herbet, A., Duray, E., Cobraiville, G., FOGUENNE, J., Boquet, D., Gothot, A., Beguin, Y., Fillet, M., & Caers, J. (2023). Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma. HemaSphere, 22, 901. doi:10.1097/HS9.0000000000000901
Peer Reviewed verified by ORBi

El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006
Peer Reviewed verified by ORBi

De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266
Peer Reviewed verified by ORBi

Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7
Peer Reviewed verified by ORBi

GREGOIRE, C.* , LAYIOS, N.* , LAMBERMONT, B., LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., THYS, M., Dardenne, N., Misset, B.* , & BEGUIN, Y.*. (04 July 2022). Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial. Frontiers in Immunology, 13, 932360. doi:10.3389/fimmu.2022.932360
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Nabergoj, M., Mauff, K., Beelen, D., Ganser, A., Kröger, N., Stölzel, F., Finke, J., Passweg, J., Cornelissen, J., Schub, N., Veelken, J. H., Beguin, Y., Wilson, K., Zuckerman, T., Hunault-Berger, M., Lioure, B., Porras, R. P., Turlure, P., Kerre, T., ... Yakoub-Agha, I. (July 2022). Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 57, 1072 - 1078. doi:10.1038/s41409-022-01686-7
Peer Reviewed verified by ORBi

El Moussaoui, M., Maes, N., Hong, S. L., Lambert, N., Gofflot, S., DELLOT, P., Belhadj, Y., Huynen, P., Hayette, M.-P., Meex, C., Bontems, S., Defêche, J., Godderis, L., Molenberghs, G., Meuris, C., Artesi, M., Durkin, K., Rahmouni, S., GREGOIRE, C., ... DARCIS, G. (14 June 2022). Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium. Viruses, 14 (6), 1302. doi:10.3390/v14061302
Peer Reviewed verified by ORBi

GREGOIRE, C.* , HUYNEN, P.* , Gofflot, S., Seidel, L., Maes, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (13 June 2022). Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12, 9790. doi:10.1038/s41598-022-13450-4
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

SERVAIS, S., BEGUIN, Y., & BARON, F. (27 May 2022). Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia. Stem Cells Translational Medicine, 11 (5), 461-477. doi:10.1093/stcltm/szac015
Peer Reviewed verified by ORBi

BARZIN, A., Geurten, C., WILLEMS, E., Baron, F., Beguin, Y., & Servais, S. (May 2022). Maladie du greffon contre l’hôte aiguë et chronique après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 77 (5-6), 345 - 353.
Editorial Reviewed verified by ORBi

Canti, L., Ariën, K. K., Desombere, I., Humblet-Baron, S., Pannus, P., Heyndrickx, L., HENRY, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., SEIDEL, L., Michiels, J., Willems, B., Goossens, M. E., Beguin, Y., Marchant, A., & Baron, F. (11 April 2022). Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients. Cancer Cell, 40 (4), 335-337. doi:10.1016/j.ccell.2022.02.005
Peer Reviewed verified by ORBi

GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211.
Editorial Reviewed verified by ORBi

HUYNEN, P.* , GREGOIRE, C.* , GOFFLOT, S., SEIDEL, L., MAES, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (25 March 2022). Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12 (1), 5156. doi:10.1038/s41598-022-09215-8
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Poiré, X., Graux, C., ORY, A., Herman, J., Baron, F., Schoemans, H., Lewalle, P., De Becker, A., Deeren, D., Berneman, Z., Kerre, T., Zachée, P., Selleslag, D., & Beguin, Y. (2022). Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS). Bone Marrow Transplantation, 57, 116-118. doi:10.1038/s41409-021-01464-x
Peer Reviewed verified by ORBi

BAYOUDH, F., JASPERS, A., Azerad, M.-A., SOMJA, J., Marechal, H., & Beguin, Y. (2022). A rare case of massive myocardial infiltration by a disseminated extra-nodal NK/T-cell lymphoma. EJHaem, 3, 547-548.
Peer Reviewed verified by ORBi

Onida, F., Sbianchi, G., Radujkovic, A., Sockel, K., Kröger, N., Sierra, J., Socié, G., Cornelissen, J., Poiré, X., Raida, L., Bourhis, J.-H., Finke, J., Passweg, J., Salmenniemi, U., Schouten, H. C., BEGUIN, Y., Martin, S., Deconinck, E., Ganser, A., ... Yakoub-Agha, I. (2022). Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP. Bone Marrow Transplantation, 57, 896-902. doi:10.1038/s41409-021-01555-9
Peer Reviewed verified by ORBi

Teyssier, A.-C., Michel, G., Jubert, C., Rialland, F., Visentin, S., Ouachée, M., Bilger, K., Gandemer, V., Beguin, Y., Marie-Cardine, A., Chalandon, Y., Ansari, M., Baumstarck, K., Loundou, A., Dalle, J.-H., & Sirvent, A. (2022). Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical Trial. Transplantation and Cellular Therapy, 28, 780.e1 - 780.e7. doi:10.1016/j.jtct.2022.08.019
Peer Reviewed verified by ORBi

BARON, F., Canti, L., Ariën, K. K., Kemlin, D., Desombere, I., Gerbaux, M., Pannus, P., BEGUIN, Y., Marchant, A., & Humblet-Baron, S. (2022). Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Frontiers in Immunology, 13, 827242. doi:10.3389/fimmu.2022.827242
Peer Reviewed verified by ORBi

Pochon, C., Detrait, M., Dalle, J.-H., Michel, G., Dhédin, N., Chalandon, Y., Brissot, E., Forcade, E., Sirvent, A., Izzadifar-Legrand, F., Michallet, M., Renard, C., Yakoub-Agha, I., Gonzales, F., Bay, J.-O., Kanold, J., Cornillon, J., Bulabois, C. E., Angoso, M., ... Rubio, M.-T. (2022). Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC). Journal of Cancer Research and Clinical Oncology, 148, 2083-2097. doi:10.1007/s00432-021-03761-w
Peer Reviewed verified by ORBi

VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323
Peer reviewed

VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154
Peer Reviewed verified by ORBi

Averbuch, D., De Greef, J., Duréault, A., Wendel, L., Tridello, G., Lebeaux, D., Mikulska, M., Gil, L., Knelange, N., Zuckerman, T., Daguindau, E., Robin, C., Xhaard, A., Aljurf, M., Beguin, Y., Le Bourgeois, A., Botella-Garcia, C., Khanna, N., Van Praet, J., ... Styczynski, J. (2022). Nocardia infections in hematopoietic cell transplant recipients: a multicenter international retrospective study of the Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Clinical Infectious Diseases, 75, 88-97. doi:10.1093/cid/ciab866
Peer Reviewed verified by ORBi

Albert, M. H., Sirait, T., Eikema, D.-J., Bakunina, K., Wehr, C., Suarez, F., Fox, M. L., Mahlaoui, N., Gennery, A. R., Lankester, A. C., Beier, R., Bernardo, M. E., Bigley, V., Lindemans, C. A., Burns, S. O., Carpenter, B., Dybko, J., Güngör, T., Hauck, F., ... Vinh, D. C. (2022). Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study. Blood, 140, 1635 - 1649. doi:10.1182/blood.2022015506
Peer Reviewed verified by ORBi

Le Calvez, B., Tessoullin, B., Renaud, L., Botella-Garcia, C., Srour, M., Le Gouill, S., Guillerm, G., Gressin, R., Nguyen Quoc, S., Furst, S., Chauchet, A., Sibon, D., Lewalle, P., Poiré, X., Maillard, N., Villate, A., Loschi, M., Paillassa, J., Beguin, Y., ... Le Bourgeois, A. (2022). Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study. Acta Oncologica, 61, 1332 - 1338. doi:10.1080/0284186X.2022.2130709
Peer Reviewed verified by ORBi

Narinx, J., Houbiers, M., Seidel, L., & Beguin, Y. (2022). Adherence to Sars-CoV2 vaccination in hematological patients. Frontiers in Immunology, 13, 994311. doi:10.3389/fimmu.2022.994311
Peer Reviewed verified by ORBi

Bay, J. O., Beguin, Y., CARPENTIER, A., Dard, C., Guillaume, T., Labussiere-Wallet, H., Lacassagne, M. N., Sauze, S., Yakoub-Agha, I., & Chalandon, Y. (2021). Comment faire face à un évènement inattendu pouvant modifier l’activité normale de thérapie cellulaire? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer, 108, 20-S25. doi:10.1016/j.bulcan.2021.05.002
Peer Reviewed verified by ORBi

Janssens, A., Selleslag, D., Depaus, J., BEGUIN, Y., & Lambert, C. (2021). Primary immune thrombocytopenia in adults. Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society. Acta Clinica Belgica, 26, 1-14. doi:10.1080/17843286.2021.1876310
Peer Reviewed verified by ORBi

Kröger, N., Sbianchi, G., Sirait, T., Wolschke, C., Beelen, D., Passweg, J., Robin, M., Vrhovac, R., Helbig, G., Sockel, K., Conneally, E., Rubio, M. T., Beguin, Y., Finke, J., Bernasconi, P., Morozova, E., Clausen, J., von dem Borne, P., Schaap, N., ... Yakoub-Agha, I. (2021). Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT. Leukemia, 35, 3551-3580. doi:10.1038/s41375-021-01276-4
Peer Reviewed verified by ORBi

LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., & BEGUIN, Y. (2021). MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process. Cells, 10, 1320. doi:10.3390/cells10061320
Peer Reviewed verified by ORBi

Courtois, J., Ritacco, C., DUBOIS, S., Canti, L., Vandenhove, B., SEIDEL, L., Daulne, C., CAERS, J., SERVAIS, S., Beguin, Y., Ehx, G., & BARON, F. (2021). Itacitinib prevents xenogeneic GVHD in humanized mice. Bone Marrow Transplantation, 56, 2672-2681. doi:10.1038/s41409-021-01363-1
Peer Reviewed verified by ORBi

Narinx, J., SERVAIS, S., BARON, F., BEGUIN, Y., & WILLEMS, E. (2021). Allogreffes de cellules souches hématopoïétiques : principes généraux et progrès récents. Revue Médicale de Liège, 76, 464-469.
Peer reviewed

Janssens, A., Selleslag, D., Depaus, J., BEGUIN, Y., & Lambert, C. (2021). Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society. Belgian Journal of Hematology, 12, 112-127.
Peer Reviewed verified by ORBi

MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481.
Peer reviewed

Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488.
Peer reviewed

SCHEEN, A., BEGUIN, Y., & JERUSALEM, G. (2021). L’oncologie, à un tournant de son histoire. Revue Médicale de Liège, 76, 297-299.
Peer reviewed

BEGUIN, Y. (2021). L’Institut de Cancérologie Arsène Burny (ICAB) et son nouveau bâtiment du Centre Intégré d’Oncologie (CIO) au CHU de Liège. Revue Médicale de Liège, 76, 300-306.
Peer reviewed

Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x
Peer Reviewed verified by ORBi

Lejeune, M., Duray, E., Peipp, M., Clémenceau, B., Baron, F., Beguin, Y., & Caers, J. (2021). Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers, 13 (12), 3072. doi:10.3390/cancers13123072
Peer Reviewed verified by ORBi

Miano, M., Eikema, D.-J., de la Fuente, J., Bosman, P., Ghavamzadeh, A., Smiers, F., Sengeløv, H., Yesilipek, A., Formankova, R., Bader, P., Díaz Pérez, M. Á., Bertrand, Y., Niemeyer, C., Diallo, S., Ansari, M., Bykova, T. A., Faraci, M., Bonanomi, S., Gozdzik, J., ... Dufour, C. (2021). Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Transplantation and Cellular Therapy, 27 (3), 274.e1-274.e5. doi:10.1016/j.jtct.2020.12.024
Peer Reviewed verified by ORBi

Ritacco, C.* , Ehx, G.* , GREGOIRE, C., Daulne, C., WILLEMS, E., SERVAIS, S., BEGUIN, Y., & Baron, F. (2021). High proportion of terminally-differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 56, 1828-1841. doi:10.1038/s41409-021-01221-0
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Duray, E., Lejeune, M., Baron, F., Beguin, Y., Devoogdt, N., Krasniqi, A., Lauwers, Y., Zhao, Y. J., D'Huyvetter, M., Dumoulin, M., & Caers, J. (2021). A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma. Journal of hematology & oncology, 14 (1), 183. doi:10.1186/s13045-021-01171-6
Peer reviewed

Xhaard, A., Xhaard, C., d'Aveni, M., Salvator, H., Chabi-Charvillat, M.-L., Coman, T., BEGUIN, Y., Chalandon, Y., Poiré, X., Loschi, M., Paillard, C., Bruno, B., Ceballos, P., Dalle, J.-H., Bilger, K., Bay, J.-O., Robin, M., N'Guyen-Quoc, S., & Rubio, M.-T. (2021). Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation : a SFGM-TC multicentre cohort study. British Journal of Haematology, 192, 121-e135. doi:10.1111/bjh.17260
Peer Reviewed verified by ORBi

Ehx, G.* , Ritacco, C.* , HANNON, M., DUBOIS, S., Delens, L., WILLEMS, E., SERVAIS, S., Drion, P., BEGUIN, Y., & Baron, F. (2021). Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. American Journal of Transplantation, 21, 2662-2674. doi:10.1111/ajt.16505
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

DE VOEGHT, A., JASPERS, A., BEGUIN, Y., Baron, F., & DE PRIJCK, B. (2021). Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique. Revue Médicale de Liège, 76, 470-475.
Peer reviewed

Canti, L.* , Humblet-Baron, S.* , Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Liston, A., Ariën, K. K., Beguin, Y., Goossens, M. E., Marchant, A., & Baron, F. (2021). Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of hematology & oncology, 14 (1), 174. doi:10.1186/s13045-021-01190-3
Peer reviewed
* These authors have contributed equally to this work.

PIROTTE, M., Fillet, M., SEIDEL, L., JASPERS, A., Baron, F., & Beguin, Y. (2021). Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant. American Journal of Hematology, 96 (10), 1275-1286. doi:10.1002/ajh.26300
Peer Reviewed verified by ORBi

Vandenhove, B., Canti, L., Schoemans, H., Beguin, Y., Baron, F., Graux, C., Kerre, T., & SERVAIS, S. (21 October 2020). How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Frontiers in Immunology, 11, 583564. doi:10.3389/fimmu.2020.583564
Peer Reviewed verified by ORBi

Lejeune, M., Köse, M. C., Duray, E., Einsele, H., Beguin, Y., & Caers, J. (07 May 2020). Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Frontiers in Immunology, 11 (762), 1-20. doi:10.3389/fimmu.2020.00762
Peer Reviewed verified by ORBi

VANDERMEULEN, M., ERPICUM, P., WEEKERS, L., BRIQUET, A., LECHANTEUR, C., Detry, O., Beguin, Y., & Jouret, F. (May 2020). Mesenchymal Stromal Cells in Solid Organ Transplantation. Transplantation, 104 (5), 923-936. doi:10.1097/TP.0000000000003077
Peer Reviewed verified by ORBi

Lejeune, M., Köse, M. C., Duray, E., Beguin, Y., & CAERS, J. (2020). Les anticorps bispécifiques ciblant les lymphocytes T dans le myélome multiple. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 14 (6), 30-34.
Peer reviewed

Snowden, J. A., Saccardi, R., Orchard, K., Ljungman, P., Duarte, R. F., Labopin, M., McGrath, E., Brook, N., Ruiz de Elvira, C., Gordon, D., Poirel, H. A., Ayuk, F., Beguin, Y., Bonifazi, F., Gratwohl, A., Milpied, N., Moore, J., Passweg, J., Rizzo, J. D., ... Putter, H. (2020). Benchmarking of Survival Outcomes following Haematopoietic Stem Cell Transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation, 55, 681-694. doi:10.1038/s41409-019-0718-7
Peer Reviewed verified by ORBi

Roex, G., Feys, T., BEGUIN, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2020). Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies : An Update of the Pivotal Clinical Trial Center. Pharmaceutics, 12, 194. doi:10.3390/pharmaceutics12020194
Peer Reviewed verified by ORBi

Vandenhove, B.* , Canti, L.* , Schoemans, H., BEGUIN, Y., BARON, F., WILLEMS, E., Graux, C., Kerre, T.* , & SERVAIS, S.*. (2020). Acute graft-versus-host disease: diagnosis, pathophysiology and prevention. Belgian Journal of Hematology, 11 (4), 159-173.
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Mamez, A.-C., Dupont, A., Blaise, D., Chavallier, P., Forcade, E., Ceballos, P., Mohty, M., Suarez, F., BEGUIN, Y., Peffault de Latour, R., Rubio, M.-T., Tournilhac, O., & Nguyen, S. (2020). Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Journal of Hematology and Oncology, 13, 56. doi:10.1186/s13045-020-00892-4
Peer Reviewed verified by ORBi

HAUZEUR, J.-P., LECHANTEUR, C., BAUDOUX, E., De Maertelaer, V., Pather, S., Katz, R., Malaise, M., Ino, J., & Beguin, Y. (2020). Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clinical Orthopaedics and Related Research, 478, 1307-1315.
Peer Reviewed verified by ORBi

Dubois, V., Amokrane, K., Beguin, Y., Bruno, B., Chevallier, P., Delbos, F., Devillier, R., Giannoli, C., Guidicelli, G., Harif, M., Loiseau, P., Rouzaire, P.-O., Varlet, P., Yakoub-Agha, I., & Nguyen, S. (2020). Greffe de cellules souches hématopoïétiques haplo-identiques avec cyclophosphamide en post-greffe : comment choisir le meilleur donneur en 2019 ? Recommandations de la Société francophone de greffe de mœlle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 107 (Suppl. 1), 72-84. doi:10.1016/j.bulcan.2019.07.011
Peer Reviewed verified by ORBi

Dhédin, N., Paillard, C., Dalle, J.-H., Ouachée, M., Buchbinder, N., Brissot, E., BEGUIN, Y., Masouridi-Levrat, S., Yakoub-Agha, I., Bernit, E., & Pondarre, C. (2020). Allogreffe de cellules souches hématopoïétiques dans la drépanocytose de l'enfant et de l'adulte : indications et modalités. Bulletin du Cancer, 107, 925-933. doi:10.1016/j.bulcan.2020.06.003
Peer Reviewed verified by ORBi

Azerad, M.-A., BAYOUDH, F., Weber, T., Minon, J.-M., Ketelsleggers, O., HOYOUX, M., Ren, X., Kaye, O., De Marneffe, N., Fraipont, V., Masset, C., Bouillon, A.-S., JASPERS, A., Tebache, M., D'Hoen, G., Habibi, A., Efira, A., Thachil, J., Deckmyn, H., & BEGUIN, Y. (2020). Sickle cell disease and COVID-19: Atypical presentations and favorable outcomes. EJHaem, 1 (jha 2.74), 338-341. doi:10.1002/jha2.74
Peer Reviewed verified by ORBi

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600
Peer Reviewed verified by ORBi

Engel, N., Rovo, A., Badoglio, M., Labopin, M., Basak, G. W., BEGUIN, Y., Guyotat, D., Ljungman, P., Nagler, A., Schattenberg, A., Schroeder, T., Schroyens, W., Tischer, J., Socie, G., Kolb, H.-J., Tichelli, A., Salooja, N., & Duarte, R. F. (2019). European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation. Leukemia, 33, 508-517. doi:10.1038/s41375-018-0218-6
Peer Reviewed verified by ORBi

JASPERS, A., & Beguin, Y. (2019). Erythropoiesis and iron metabolism after hematopoietic stem cell transplantation. Belgian Journal of Hematology, 10, 89-95.
Peer Reviewed verified by ORBi

Delens, L., Ehx, G., SOMJA, J., Vrancken, L., Belle, L., SEIDEL, L., Grégoire, C., Fransolet, G., Ritacco, C., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & Servais, S. (2019). In Vitro Th17-Polarized Human CD4(+) T Cells Exacerbate Xenogeneic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation, 25, 204-215. doi:10.1016/j.bbmt.2018.10.007
Peer Reviewed verified by ORBi

Fitzgerald, S. P., Grote Beverborg, N., Beguin, Y., Artunc, F., Falhammar, H., & Bean, N. G. (2019). Population data provide evidence against the presence of a set point for hemoglobin levels or tissue oxygen delivery. Physiological Reports, 7 (12), 14153. doi:10.14814/phy2.14153
Peer Reviewed verified by ORBi

Zephir, H., Puyade, M., Gueguen, A., Michel, L., Terriou, L., Dive, D., Laureys, G., Mathey, G., Labauge, P., Marjanovic, Z., Pugnet, G., Badoglio, M., Lansiaux, P., Ibrahim, Y.-A., Beguin, Y., & Farge, D. (2019). Indications de l'autogreffe dans la sclérose en plaques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) en lien avec la Société francophone de la sclérose en plaques. Bulletin du Cancer, 106 (Suppl. 1), 92-101. doi:10.1016/j.bulcan.2018.11.002
Peer Reviewed verified by ORBi

Caulier, A., Drumez, E., Gauthier, J., Robin, M., Blaise, D., Beguin, Y., Michallet, M., Chevallier, P., Bay, J.-O., Vigouroux, S., Desbrosses, Y., Cornillon, J., Nguyen, S., Dauriac, C., de Latour, R. P., Lioure, B., Rohrlich, P.-S., Carré, M., Bourhis, J.-H., ... Yakoub-Agha, I. (2019). Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC. Current Research in Translational Medicine, 67, 8-15. doi:10.1016/j.retram.2018.08.003
Peer Reviewed verified by ORBi

Nagler, A., Labopin, M., Dholaria, B., Niittyvuopio, R., Maertens, J., Poiré, X., Cornelissen, J., Reményi, P., Bourhis, J. H., Beguin, Y., Malladi, R., Kerre, T., Schroyens, W., Savani, B. N., & Mohty, M. (2019). Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. Blood Advances, 3 (13), 1950-1960. doi:10.1182/bloodadvances.2019000030
Peer Reviewed verified by ORBi

Jaimes-Albornoz, D., Mannone, L., Nguyen-Quoc, S., Chalandon, Y., Chevallier, P., Mohty, M., Meunier, M., Robin, M., Ledoux, M.-P., Guillerm, G., Bay, J.-O., Poiré, X., Maillard, N., Leclerc, M., Daguindau, E., Beguin, Y., Rubio, M. T., & Gyan, E. (2019). Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation, 25, 2366-2374. doi:10.1016/j.bbmt.2019.07.013
Peer Reviewed verified by ORBi

Feyx, T., Roex, G., Beguin, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2019). Chimeric antigen receptor T-cells: a new therapeutic option for relapsed/refractory B-cell malignancies and beyond. Belgian Journal of Hematology, 10, 301-310.
Peer Reviewed verified by ORBi

Grégoire, C., Ritacco, C., Hannon, M., SEIDEL, L., Delens, L., Belle, L., DUBOIS, S., Veriter, S., LECHANTEUR, C., BRIQUET, A., Servais, S., Ehx, G., Beguin, Y., & Baron, F. (2019). Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Frontiers in Immunology, 10, 619. doi:10.3389/fimmu.2019.00619
Peer Reviewed verified by ORBi

Muller, J., Duray, E., Lejeune, M., DUBOIS, S., Plougonven, E., Léonard, A., Storti, P., Giuliani, N., Cohen-Solal, M., Hempel, U., Thijssen, V., BEGUIN, Y., Heusschen, R., & CAERS, J. (2019). Loss of stromal galectin-1 enhances multiple myeloma development: Emphasis on a role in osteoclasts. Cancers, 11 (2), 261. doi:10.3390/cancers11020261
Peer Reviewed verified by ORBi

Antoine-Poirel, H., Vanspauwen, M., Macq, G., De Geyndt, A., Maertens, J., WILLEMS, E., Selleslag, D., Poiré, X., Theunissen, K., Graux, C., Kerre, T., Zachée, P., Meuleman, N., De Becker, A., Verlinden, A., Van Obbergh, F., Schuermans, C., De Wilde, V., JASPERS, A., ... Beguin, Y. (2019). Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres. Bone Marrow Transplantation, 54, 1434-1442. doi:10.1038/s41409-019-0458-8
Peer Reviewed verified by ORBi

ERPICUM, P., WEEKERS, L., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., GREGOIRE, C., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., MAGGIPINTO, G., SOMJA, J., Pottel, H., Baron, F., Jouret, F., & BEGUIN, Y. (2019). Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International, 95, 693-707. doi:10.1016/j.kint.2018.08.046
Peer Reviewed verified by ORBi

Cremers, E., de Witte, T., de Wreede, L., Eikema, D.-J., Koster, L., van Biezen, A., Finke, J., Socié, G., Beelen, D., Maertens, J., Nagler, A., Kobbe, G., Ziagkos, D., Itälä-Remes, M., Gedde-Dahl, T., Sierra, J., Niederwieser, D., Ljungman, P., Beguin, Y., ... Kröger, N. (2019). A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation *. Leukemia and Lymphoma, 60, 2404-2414. doi:10.1080/10428194.2019.1594215
Peer Reviewed verified by ORBi

Fayard, A., Daguenet, E., Blaise, D., Chevallier, P., Labussière, H., Berceanu, A., Yakoub-Agha, I., Socié, G., Charbonnier, A., Suarez, F., Huynh, A., Mercier, M., Bulabois, C.-E., Lioure, B., Chantepie, S., Beguin, Y., Bourhis, J.-H., Malfuson, J.-V., Clément, L., ... Cornillon, J. (2019). Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation, 54, 1586-1594. doi:10.1038/s41409-019-0475-7
Peer Reviewed verified by ORBi

GREGOIRE, C., BRIQUET, A., PIRENNE, C., LECHANTEUR, C., LOUIS, E.* , & BEGUIN, Y.*. (November 2018). Allogeneic mesenchymal stromal cells for refractory luminal Crohn's disease: A phase I-II study. Digestive and Liver Disease, 50 (11), 1251-1255. doi:10.1016/j.dld.2018.08.015
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Farhat, K., Bodart, G., Charlet-Renard, J. D. C., Desmet, C., Moutschen, M., Beguin, Y., Baron, F., Melin, P., Quatresooz, P., Parent, A.-S., Desmecht, D., Sirard, J.-C., Salvatori, R., Martens, H., & Geenen, V. (02 October 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Frontiers in Immunology, 9, 2175. doi:10.3389/fimmu.2018.02175
Peer Reviewed verified by ORBi

Heusschen, R., Muller, J., Duray, E., WITHOFS, N., Bolomsky, A., Baron, F., Beguin, Y., Menu, E., Ludwig, H., & Caers, J. (2018). Molecular mechanisms, current management and next generation therapy in myeloma bone disease. Leukemia and Lymphoma, 59, 14-28. doi:10.1080/10428194.2017.1323272
Peer Reviewed verified by ORBi

Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., Lejeune, M., Léonard, A., Marty, C., Hempel, U., Baron, F., BEGUIN, Y., Cohen-Solal, M., Ludwig, H., Heusschen, R., & CAERS, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity on multiple myeloma bone disease. Haematologica, 103, 1359-1368. doi:10.3324/haematol.2017.185397
Peer Reviewed verified by ORBi

Trento, C., Bernardo, M. E., Nagler, A., Kuçi, S., Bornhäuser, M., Köhl, U., Strunk, D., Galleu, A., Sanchez-Guijo, F., Gaipa, G., Introna, M., Bukauskas, A., Le Blanc, K., Apperley, J., Roelofs, H., Van Campenhout, A., Beguin, Y., Kuball, J., Lazzari, L., ... Dazzi, F. (2018). Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 24, 2365-2370. doi:10.1016/j.bbmt.2018.07.015
Peer Reviewed verified by ORBi

Paviglianiti, A., Tozatto Maio, K., Rocha, V., Gehlkopf, E., Milpied, N., Esquirol, A., Chevallier, P., Blaise, D., Gac, A.-C., Leblond, V., Cahn, J. Y., Abecasis, M., Zuckerman, T., Schouten, H., Gurman, G., Rubio, M. T., Beguin, Y., Corral, L. L., Nagler, A., ... Ruggeri, A. (2018). Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study. Biology of Blood and Marrow Transplantation, 24, 2265-2270. doi:10.1016/j.bbmt.2018.07.019
Peer Reviewed verified by ORBi

Van de Velde, A., Willekens, B., Vanopdenbosch, L., Deryck, O., Selleslag, D., D'Haeseleer, M., De Becker, A., Dubois, B., Dierickx, D., Perrotta, G., De Wilde, V., van Pesch, V., Straetmans, N., Dive, D., Beguin, Y., Van Wijmeersch, B., Theunissen, K., Kerre, T., & Laureys, G. (2018). A Belgian consensus protocol for autologous haematopoietic stem cell transplantation in multiple sclerosis. Belgian Journal of Hematology, 9, 167-174.
Peer Reviewed verified by ORBi

HAUZEUR, J.-P., De Maertelaer, V., BAUDOUX, E., MALAISE, M., Beguin, Y., & Gangji, V. (2018). Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics, 42, 1429-1435. doi:10.1007/s00264-017-3650-8
Peer Reviewed verified by ORBi

Ehx, G., SOMJA, J., Warnatz, H.-J., Ritacco, C., HANNON, M., Delens, L., Fransolet, G., DELVENNE, P., Muller, J., BEGUIN, Y., Lehrach, H., Belle, L., Humblet-Baron, S., & BARON, F. (2018). Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice. Frontiers in Immunology, 9, 1943. doi:10.3389/fimmu.2018.01943
Peer Reviewed verified by ORBi

Decroocq, J., Itzykson, R., Vigouroux, S., Michallet, M., Yakoub-Agha, I., Huynh, A., Beckerich, F., Suarez, F., Chevallier, P., Nguyen-Quoc, S., Ledoux, M.-P., Clement, L., Hicheri, Y., Guillerm, G., Cornillon, J., Contentin, N., Carre, M., Maillard, N., Mercier, M., ... Dhedin, N. (2018). Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire. American Journal of Hematology, 93 (3), 416-423. doi:10.1002/ajh.25004
Peer Reviewed verified by ORBi

McLornan, D. P., Szydlo, R., Robin, M., van Biezen, A., Koster, L., Blok, H. J. P., Van Lint, M. T., Finke, J., Vitek, A., Carlson, K., Griskevicius, L., Holler, E., Itala-Remes, M., Schaap, M., Socie, G., Bay, J.-O., BEGUIN, Y., Bruno, B., Cornelissen, J. J., ... Kroger, N. (2018). Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. British Journal of Haematology, 182, 418-422. doi:10.1111/bjh.15407
Peer Reviewed verified by ORBi

Lewalle, P., & Beguin, Y. (2018). Extracorporeal photochemotherapy for graft versus host disease : Where we are now and where are we going ! Belgian Journal of Hematology, 9, 254-265.
Peer Reviewed verified by ORBi

Akhtar, S., Montoto, S., Boumendil, A., Finel, H., Masszi, T., Jindra, P., Nemet, D., Fuhrmann, S., Beguin, Y., Castagna, L., Ferrara, F., Capria, S., Malladi, R., Moraleda, J. M., Bloor, A., Ghesquières, H., Meissner, J., Sureda, A., & Dreger, P. (2018). High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party. American Journal of Hematology, 93 (1), 40-46. doi:10.1002/ajh.24927
Peer Reviewed verified by ORBi

Laureys, G., Willekens, B., Vanopdenbosch, L., Deryck, O., Selleslag, D., D'Haeseleer, M., De Becker, A., Dubois, B., Dierickx, D., Perrotta, G., De Wilde, V., van Pesch, V., Straetmans, N., Dive, D., Beguin, Y., Van Wijmeersch, B., Theunissen, K., Kerre, T., & Van de Velde, A. (2018). A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis. Acta Neurologica Belgica, 118 (2), 161-168. doi:10.1007/s13760-018-0905-0
Peer Reviewed verified by ORBi

Gauthier, J., Poiré, X., Gac, A.-C., Leclerc, M., Guillaume, T., Chalandon, Y., Nguyen, S., Forcade, E., Régny, C., Bay, J.-O., Bazarbachi, A., Rohrlich, P.-S., Huynh, A., Farhi, J., Marchand, T., Malfuson, J.-V., Pilorge, S., Labussière-Wallet, H., Renard, C., ... Yakoub-Agha, I. (2018). Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation - A study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 53 (4), 400-409. doi:10.1038/s41409-017-0018-z
Peer Reviewed verified by ORBi

Vrancken, L., Muller, J., Lejeune, M., Grégoire, C., Delens, L., Jaspers, A., Servais, S., DE PRIJCK, B., Baron, F., Caers, J., & Beguin, Y. (2018). Nouveautes dans la prise en charge du myelome. Revue Médicale Suisse, 14 (615), 1438-1442.
Peer Reviewed verified by ORBi

Servais, S., Baron, F., LECHANTEUR, C., SEIDEL, L., Selleslag, D., Maertens, J., BAUDOUX, E., Zachee, P., Van Gelder, M., Noens, L., Kerre, T., Lewalle, P., Schroyens, W., ORY, A., & Beguin, Y. (2018). Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study. Oncotarget, 9 (29), 20590-20604. doi:10.18632/oncotarget.25020
Peer Reviewed verified by ORBi

Devos, T., BEGUIN, Y., Noens, L., Van Eygen, K., Zachée, P., Mineur, P., Knoops, L., Doyen, C., Theunissen, K., Benghiat, F. S., Reusens, M., & Pluymers, W. (2018). Disease and treatment characteristics of polycythaemia vera patients in Belgium : results from a scientific survey. European Journal of Haematology, 100, 361-366. doi:10.1111/ejh.13022
Peer Reviewed verified by ORBi

Pirotte, M.* , Forte, F.* , Lutteri, L., WILLEMS, E., DURAN, U., Belle, L., Baron, F., BEGUIN, Y., Maquet, P., BODART, O.* , & Servais, S.*. (2018). Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Journal of Neuroimmunology, 323, 115-118. doi:10.1016/j.jneuroim.2018.08.003
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Caers, J., Garderet, L., Kortum, K. M., O'Dwyer, M. E., van de Donk, N. W. C. J., Binder, M., Dold, S. M., Gay, F., Corre, J., Beguin, Y., Ludwig, H., Larocca, A., Driessen, C., Dimopoulos, M. A., Boccadoro, M., Gramatzki, M., Zweegman, S., Einsele, H., Cavo, M., ... Engelhardt, M. (2018). European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica, 103, 1172-1184. doi:10.3324/haematol.2018.189159
Peer Reviewed verified by ORBi

Aapro, M. S., Beguin, Y., Bokemeyer, C., Dicato, M., Gascon, P., Glaspy, J. A., Hofmann, A., Link, H., Littlewod, T., Ludwig, H., Osterborg, A., Pronzato, P., Santini, V., Schrijvers, D., Stauder, R., & Herrstedt, J. (2018). Management of anaemia and iron deficiency in patients with cancer : ESMO Clinical Practice Guidelines. Annals of Oncology, 29, 96-110. doi:10.1093/annonc/mdx758
Peer Reviewed verified by ORBi

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001
Peer Reviewed verified by ORBi

Heusschen, R., Muller, J., WITHOFS, N., BARON, F., BEGUIN, Y., & CAERS, J. (2017). Multiple myeloma bone disease: from mechanisms to next generation therapy. Belgian Journal of Hematology, 8, 66-74.
Peer Reviewed verified by ORBi

Van Obbergh, F., Knoops, L., Devos, T., BEGUIN, Y., Graux, C., Benghiat, S., Kargar-Samani, K., Bauwens, D., Efira, A., Dubois, C., Springael, C., Montfort, L., Connerotte, T., Delannoy, A., & Wallemacq, P. (2017). The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clinical Biochemistry, 50, 452-454. doi:10.1016/j.clinbiochem.2016.12.006
Peer Reviewed verified by ORBi

Heidenreich, S., Ziagkos, D., De Wreede, L., Van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schleuning, M., Beelen, D., Tischer, J., Nagler, A., Glass, B., Maertens, J., Yanez, L., BEGUIN, Y., Sill, H., Scheid, C., ... Kröger, N. (2017). Allogeneic stem cell transplantation for patients with myelodysplastic syndrome 70 years of age or older: A retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT. Biology of Blood and Marrow Transplantation, 23, 44-52. doi:10.1016/j.bbmt.2016.09.027
Peer Reviewed verified by ORBi

GREGOIRE, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., BARON, F., LOUIS, E., & BEGUIN, Y. (2017). Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 45, 205-221. doi:10.1111/apt.13864
Peer Reviewed verified by ORBi

Ehx, G., Fransolet, G., De Leval, L., D'Hondt, S., Lucas, S., Hannon, M., Delens, L., DUBOIS, S., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (2017). Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects. Oncoimmunology, 6:e1314425. doi:10.1080/2162402X.2017.1314425
Peer Reviewed verified by ORBi

Libert, Y., Borghgraef, C., Beguin, Y., Delvaux, N., DEVOS, M., Doyen, C., Dubruille, S., Etienne, A.-M., Liénard, A., Merckaert, I., Reynaert, C., Slachmuylder, J.-L., Straetmans, N., Van Den Neste, E., Bron, D., & Razavi, D. (2017). Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort study. Psycho-oncology, 26 (12), 2086-2093. doi:10.1002/pon.4424
Peer Reviewed verified by ORBi

SERVAIS, S., Hannon, M., Peffault de Latour, R., Socie, G., & BEGUIN, Y. (2017). Reconstitution of adaptive immunity after umbilical cord blood transplantation and clinical implication regarding risk of infections. Stem Cell Investigation, 4, 40.
Peer Reviewed verified by ORBi

Gauthier, J., Castagna, L., Garnier, F., Guillaume, T., Socié, G., Maury, S., Maillard, N., Tabrizi, R., Marchand, T., Malfuson, J.-V., Gac, A.-C., Gyan, E., Mercier, M., BEGUIN, Y., Delage, J., Turlure, P., Marcais, A., Nguyen, S., Dulery, R., ... Blaise, D. (2017). Reduced intensity and non-myeloablative allogenic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin's lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 52, 689-696. doi:10.1038/bmt.2016.34
Peer Reviewed verified by ORBi

Libert, Y., Borghgraef, C., BEGUIN, Y., Delvaux, N., DEVOS, M., Doyen, C., Dubruille, S., Etienne, A.-M., Lienard, A., Merckaert, I., Slachmuylder, J., Straetmans, N., Van Den Neste, E., Bron, D., & Razavi, D. (2017). Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study. Psycho-oncology, 26, 118-124. doi:10.1002/pon.4108
Peer Reviewed verified by ORBi

Roth-Guepin, G., Canaani, J., Ruggeri, A., Labopin, M., Finke, J., Cornelissen, J. J., Delage, J., Stuhler, G., Rovira, M., Potter, M., Stadler, M., Veelken, H., Cahn, J. Y., Collin, M., Beguin, Y., Giebel, S., Nagler, A., & Mohty, M. (2017). Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT. Oncotarget, 8 (68), 112972-112979. doi:10.18632/oncotarget.22934
Peer Reviewed verified by ORBi

Roux, C., Tifratene, K., Socié, G., Galambrun, C., Bertrand, Y., Rialland, F., Jubert, C., Pochon, C., Paillard, C., Sirvent, A., Nelken, B., Vannier, J.-P., Freycon, C., BEGUIN, Y., Raus, N., Yakoub-Agha, I., Mohty, M., Dalle, J.-H., Michel, G., ... Rohrlich, P.-S. (2017). Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 52, 678-682. doi:10.1038/bmt.2016.360
Peer Reviewed verified by ORBi

Magro, L., Forcade, E., Giraud, C., Granata, A., Parquet, N., Rohrlich, P.-S., Terriou, L., Yakoub-Agha, I., & Beguin, Y. (2017). Prise en charge de la maladie du greffon contre l'hôte chronique : Recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 104S, 145-S168. doi:10.1016/j.bulcan.2017.10.023
Peer Reviewed verified by ORBi

Vrancken, L., Delens, L., BEGUIN, Y., BARON, F., & SERVAIS, S. (2017). Focus sur les lymphocytes T dans la maladie du greffon contre l'hôte après allogreffe de cellules soucges hématopoïétiques: implications pour de nouvelles stratégies de prévention. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 11, 23-31.
Peer reviewed

Sticca, T., CABERG, J.-H., Wenric, S., Poulet, C., HERENS, C., JAMAR, M., Josse, C., El Guendi, S., MAX, S., BEGUIN, Y., GOTHOT, A., CAERS, J., & Bours, V. (2017). Genomic Studies of Multiple Myeloma Reveal an Association between X Chromosome Alterations and Genomic Profile Complexity. Genes, Chromosomes and Cancer, 56, 18-27. doi:10.1002/gcc.22397
Peer Reviewed verified by ORBi

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845
Peer Reviewed verified by ORBi

Averbuch, D., Tridello, G., Hoek, J., Mikulska, M., Akan, H., Yaňez San Segundo, L., Pabst, T., Özçelik, T., Klyasova, G., Donnini, I., Wu, D., Gülbas, Z., Zuckerman, T., Botelho De Sousa, A., Beguin, Y., Xhaard, A., Bachy, E., Ljungman, P., De La Camara, R., ... Cesaro, S. (2017). Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group. Clinical Infectious Diseases, 65 (11), 1819-1828. doi:10.1093/cid/cix646
Peer Reviewed verified by ORBi

Belle, L.* , Fransolet, G.* , Somja, J., BINSFELD, M., Delvenne, P., Drion, P., Hannon, M., BEGUIN, Y., Ehx, G.* , & Baron, F.*. (12 December 2016). Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease. PLoS ONE, 11, 0167997. doi:10.1371/journal.pone.0167997
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Fransolet, G.* , Ehx, G.* , SOMJA, J., Delens, L., Hannon, M., Muller, J., DUBOIS, S., Drion, P., CAERS, J., Humblet-Baron, S., DELVENNE, P., BEGUIN, Y., Conteduca, G.* , & BARON, F.*. (04 July 2016). Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease. Journal of Hematology and Oncology, 9, 53. doi:10.1186/s13045-016-0281-2
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

SERVAIS, S., BEGUIN, Y., Delens, L., Ehx, G., Fransolet, G., Hannon, M., WILLEMS, E., Humblet-Baron, S., Belle, L., & Baron, F. (11 May 2016). Novel approaches for preventing acute graftversus- host disease after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Investigational Drugs, 9, 957-972. doi:10.1080/13543784.2016.1182498
Peer Reviewed verified by ORBi

Grégoire, C., GUIOT, J., Vertenoeil, G., WILLEMS, E., HAFRAOUI, K., CORHAY, J.-L., LOUIS, R., & BEGUIN, Y. (February 2016). Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myeloma. Acta Clinica Belgica, 71, 428-430. doi:10.1080/17843286.2015.1122872
Peer Reviewed verified by ORBi

Guièze, R., Damaj, G., Pereira, B., Robin, M., Chevallier, P., Michallet, M., Vigouroux, S., BEGUIN, Y., Blaise, D., Roosweil, D., Thiebaut, A., Rohrlich, P.-S., Huynh, A., Cornillon, J., Contentin, N., Suarez, F., Lioure, B., Mohty, M., Maillard, N., ... yakoub-Agha, I. (2016). Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies. Biology of Blood and Marrow Transplantation, 22, 240-247. doi:10.1016/j.bbmt.2015.07.037
Peer Reviewed verified by ORBi

El Cheikh, J., Sfumato, P., Sobh, M., Fegueux, N., Mohty, M., Vigouroux, S., BEGUIN, Y., Yakoub-Agha, I., Socié, G., Cornillon, J., Mercier, M., Bay, J., Blaise, D., Michallet, M., & Peffault de Latour, R. (2016). Allogenic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study for the French society for stem cell transplantation (SFGM-TC). Haematologica, 101, 262-265.
Peer Reviewed verified by ORBi

SERVAIS, S., GREGOIRE, C., BARON, F., WILLEMS, E., BRIQUET, A., BAUDOUX, E., DELLOYE, O., GIET, O., LECHANTEUR, C., & BEGUIN, Y. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Belgian Journal of Hematology, 7, 229-235.
Peer Reviewed verified by ORBi

Pirotte, M., GUIOT, J., BEGUIN, Y., & Louis, R. (2016). L'anémie dans la bronchopneumopathie chronique obstructive sévère: une comorbidité plus fréquente que l'on ne croit. Revue Médicale de Liège, 71 (11), 488-494.
Peer reviewed

CAERS, J., de Larrea, C., Leleu, X., Heusschen, R., Zojer, N., Decaux, O., Kastritis, E., Minnema, M., Jurczyszyn, A., Beguin, Y., Wäsch, R., Palumbo, A., Dimopoulos, M., Mateos, M. V., Ludwig, H., & Engelhardt, M. (2016). The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective. Oncologist, 21, 333-342. doi:10.1634/theoncologist.2015-0303
Peer Reviewed verified by ORBi

Heusschen, R.* , Muller, J.* , Binsfeld, M., Marty, C., Plougonven, E., DUBOIS, S., Mahli, N., Moermans, K., Carmeliet, G., Léonard, A., BARON, F., BEGUIN, Y., Menu, E., Cohen-Solal, M., & CAERS, J. (2016). SRC Kinase Inhibition with Saracatinib Limits the Development of Osteolytic Bone Disease in Multiple Myeloma. Oncotarget, 7, 30712-30729. doi:10.18632/oncotarget.8750
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

JASPERS, A., Bouhya, S., Belaiche, S., Chevallier, P., Hermet, E., Hospital-Gustems, C., Michallet, M., Rialland, F., Samsonova, O., Sirvent, A., Yakoub-Agha, I., Rohrlich, P.-S., & BEGUIN, Y. (2016). Evaluation et prise en charge de la surcharge en fer post-greffe recommandations de la SFGM-TC. Bulletin du Cancer, 103, 255-S266. doi:10.1016/j.bulcan.2016.09.003
Peer Reviewed verified by ORBi

Mamez, Levy, V., Chevallier, P., Blaise, D., Vigouroux, S., Xhaard, A., Fegueux, N., Contentin, N., BEGUIN, Y., Ifrah, N., Bulabois, C., Suarez, F., Yakoub-Agha, I., Turlure, P., Deconink, E., Lamy, T., Cahn, J.-Y., Huynh, A., Maury, S., ... Nguyen, S. (2016). Effet of immune modulation in relapsed peripheral T-cell lymphomas after allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 51, 358-364. doi:10.1038/bmt.2015.280
Peer Reviewed verified by ORBi

LECHANTEUR, C., BRIQUET, A., GIET, O., DELLOYE, O., BAUDOUX, E., & BEGUIN, Y. (2016). Clinical - scale expansion of mesenchymal stromal cells: a large banking experience. Journal of Translational Medicine, 14, 145-159. doi:10.1186/s12967-016-0892-y
Peer Reviewed verified by ORBi

VALDES SOCIN, H. G., SID, S., LUTTERI, L., POLUS, M., Louis, E., Beguin, Y., & Beckers, A. (2016). Le syndrome thyro-gastrique auto-immun : actualités cliniques et thérapeutiques. Vaisseaux, Coeur, Poumons, 21 (4), 40-45.
Peer reviewed

Binsfeld, M., Muller, J., Lamour, V., De Veirman, K., De Raeve, H., Bellahcene, A., Van Valckenborgh, E., BARON, F., BEGUIN, Y., CAERS, J., & Heusschen, R. (2016). Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma. Oncotarget, 7, 37931-37943. doi:10.18632/oncotarget.9270
Peer Reviewed verified by ORBi

Baron, F., & Beguin, Y. (2016). Prophylactic donor lymphocyte infusion in patients with high-risk acute myeloid leukemia: ready for prime time? Bone Marrow Transplantation, 51, 640-42. doi:10.1038/bmt.2016.38
Peer Reviewed verified by ORBi

JASPERS, A., Baron, F., SERVAIS, S., LEJEUNE, M., WILLEMS, E., SEIDEL, L., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (September 2015). Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival. American Journal of Hematology, 90 (9), 197-199. doi:10.1002/ajh.24100
Peer Reviewed verified by ORBi

HANNON, M., BEGUIN, Y., Ehx, G., SERVAIS, S., SEIDEL, L., Graux, C., Maertens, J., Kerre, T., Daulne, C., de Bock, M., Fillet, M., ORY, A., WILLEMS, E., GOTHOT, A., Humblet-Baron, S., & BARON, F. (15 July 2015). Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning. Clinical Cancer Research, 21 (14), 3131-9. doi:10.1158/1078-0432.CCR-14-3374
Peer Reviewed verified by ORBi

WITHOFS, N., NANNI, C., SIMONI, P., FANTI, S., BEGUIN, Y., & CAERS, J. (20 March 2015). Imaging myeloma and related monoclonal plasma cell disorders using MRI, low dose whole-body CT and FDG PET/CT. Clinical and Translational Imaging, 3, 95-109. doi:10.1007/s40336-015-0119-x
Peer reviewed

Benghiat, F., Beguin, Y., Dessars, B., Devos, T., Lewalle, P., Mineur, P., Straetmans, N., Van Eygen, K., Verhoef, G., & Knoops, L. (2015). Practical management of Chronic Myeloid Leukemia in Belgium. Belgian Journal of Hematology, 6 (1), 16-32.
Peer Reviewed verified by ORBi

BONNET, C., Janssens, A., Wu, K., Schroyens, W., Van Hende, V., Heimann, P., Tousseyn, T., André, M., Bron, D., Van Hoof, A., Verhoef, G., DE PRIJCK, B., Beguin, Y., & Dierickx, D. (2015). BHS guidelines for the treatment of Burkitt lymphoma. Belgian Journal of Hematology, 6 (2), 61-69.
Peer Reviewed verified by ORBi

Rowart, P., ERPICUM, P., Detry, O., WEEKERS, L., Grégoire, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2015). Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. Journal of Immunology Research, 602597. doi:10.1155/2015/602597
Peer Reviewed verified by ORBi

Guillaume, T., Beguin, Y., Tabrizi, R., Nguyen, S., Blaise, D., Deconinck, E., Redjoul, R., Cornillon, J., Guillerm, G., Contentin, N., Sirvent, A., Turlure, P., Salmon, A., Huynh, A., Francois, S., Peffault de Latour, R., Yakoub-Agha, I., & Mohty, M. (2015). Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC). European Journal of Haematology, 94, 265-269. doi:10.1111/ejh.12430
Peer Reviewed verified by ORBi

Beguin, Y., Selleslag, D., Meers, S., Graux, C., Bries, G., Deeren, D., Vrelust, I., Ravoet, C., Theunissen, K., Voelter, V., Potier, H., Trullemans, F., Noens, L., & Mineur, P. (2015). Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey. Acta Clinica Belgica, 70, 34-43. doi:10.1179/2295333714Y.0000000102
Peer Reviewed verified by ORBi

Leclerc, M., Suarez, F., Noël, M.-P., Vekhoff, A., Troussard, X., Claisse, J.-F., Thieblemont, C., Maloisel, F., Beguin, Y., Tamburini, J., Barbe, C., & Delmer, A. (2015). Rituximab therapy for hairy cell leukemia : a retrospective study of 41 cases. Annals of Hematology, 94, 89-95. doi:10.1007/s00277-014-2175-0
Peer Reviewed verified by ORBi

SID, S., Dugauquier, C., DE PRIJCK, B., BONNET, C., & Beguin, Y. (2015). Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 6 (2), 74-78.
Peer Reviewed verified by ORBi

Devos, T., Zachée, P., Bron, D., Noens, L., Van Droogenbroeck, J., Mineur, P., Beguin, Y., Berneman, Z., Benghiat, F. S., Kentos, A., Chatelain, C., Demuynck, H., Lemmens, J., Van Eygen, K., Theunissen, K., Trullemans, F., Pierre, P., Pluymers, W., & Knoops, L. (2015). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica, 70 (2), 105-111. doi:10.1179/2295333714Y.0000000097
Peer Reviewed verified by ORBi

Servais, S., BAUDOUX, E., Brichard, B., Bron, D., Debruyn, C., De Bruyère, M., De Hemptinne, D., Deneys, V., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Van Cauwenberge, J., Cornu, G., Delforge, A., & Beguin, Y. (January 2015). Circadian and circannual variations in cord blood hematopoietic cell composition. Haematologica, 100 (1), 32-34. doi:10.3324/haematol.2014.115394
Peer Reviewed verified by ORBi

Gauthier, J., Damaj, G., Langlois, C., Robin, M., Michallet, M., Chevallier, P., Beguin, Y., N'guyen, S., Bories, P., Blaise, D., Cornillon, J., Clavert, A., Mohty, M., Huynh, A., Thiébaut-Bertrand, A., Vigouroux, S., Duhamel, A., & Yakoub-Agha, I. (2015). Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the Société Française de Greffe de Moelle et Thérapies Cellulaires. Transplantation, 99 (8), 1672-1680.
Peer Reviewed verified by ORBi

Binsfeld, M., HANNON, M., Otjacques, E., Humblet-Baron, S., BAUDOUX, E., BEGUIN, Y., BARON, F., & CAERS, J. (2015). Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation. Cancer Immunology, Immunotherapy, 64, 989-998. doi:10.1007/s00262-015-1708-2
Peer Reviewed verified by ORBi

Ehx, G.* , Hannon, M.* , BEGUIN, Y., Humblet-Baron, S.* , & BARON, F.*. (2015). Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets. Oncotarget, 6, 43255-43266. doi:10.18632/oncotarget.6486
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Baron, F., Zachée, P., Maertens, J., Kerre, T., ORY, A., SEIDEL, L., Graux, C., Lewalle, P., Van Gelder, M., Theunissen, K., WILLEMS, E., Emonts, M.-P., De Becker, A., & Beguin, Y. (2015). Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. Journal of Hematology and Oncology, 8, 4. doi:10.1186/s13045-014-0098-9
Peer Reviewed verified by ORBi

SERVAIS, S., Baron, F., & BEGUIN, Y. (2015). Impact of graft source and composition on outcomes after allogeneic stem cell transplantation. Belgian Journal of Hematology, 6 (4), 162-168.
Peer Reviewed verified by ORBi

SERVAIS, S., Menten-Dedoyart, C., Beguin, Y., SEIDEL, L., Gothot, A., Daulne, C., WILLEMS, E., Delens, L., Humblet-Baron, S., Hannon, M., & Baron, F. (2015). Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation. PLoS ONE, 10 (6), 0130026. doi:10.1371/journal.pone.0130026
Peer Reviewed verified by ORBi

Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556.
Peer Reviewed verified by ORBi

Basak, G., Wiktor-Jedrzejczak, W., Labopin, M., Schoemans, H., Ljungman, P., Kobbe, G., Beguin, Y., Lang, P., Koenecke, C., Sykora, K., te Boome, L., van Biezen, A., van der Werf, S., Mohty, M., de Witte, T., Marsh, J., Dreger, P., Kröger, N., Duarte, R., & Ruutu, T. (2015). Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT. American Journal of Transplantation, 15, 705-714. doi:10.1111/ajt.13017
Peer Reviewed verified by ORBi

Halter, J., Michael, W., Schüpbach, W., Mandel, H., Casali, C., Orchard, K., Collin, M., Valcarcel, D., Rovelli, A., Filosto, M., Dotti, M., Marotta, G., Pintos, G., Barba, P., Accarino, A., Ferra, C., Illa, I., Beguin, Y., Bakker, J., ... Hirano, M. (2015). Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain: a Journal of Neurology, 138, 2847-2858. doi:10.1093/brain/awv226
Peer Reviewed verified by ORBi

DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56.
Peer reviewed

MOERMANS, C., BONNET, C., WILLEMS, E., Baron, F., NGUYEN DANG, D., HENKET, M., Sele, J., CORHAY, J.-L., Beguin, Y., & Louis, R. (November 2014). Sputum cytokines levels in patients undergoing hematopoietic SCT (HSCT) and comparison with healthy subjects and COPD: a pilot study. Bone Marrow Transplantation, 49 (11), 1382-1388. doi:10.1038/bmt.2014.164
Peer Reviewed verified by ORBi

Delens, L., Jouret, F., DETRY, O., Beguin, Y., & Krzesinski, J.-M. (27 August 2014). Intérêt des cellules stromales mésenchymateuses en transplantation d’organes solides. Revue Médicale Suisse, 10, 1538-1543.
Peer Reviewed verified by ORBi

De Bock, M., BEGUIN, Y., Leprince, P., WILLEMS, E., BARON, F., Deroyer, C., Seidel, L., CAVALIER, E., DE SENY, D., MALAISE, M., GOTHOT, A., MERVILLE, M.-P., & Fillet, M. (July 2014). Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkers. Talanta, 125, 265-275. doi:10.1016/j.talanta.2014.03.017
Peer Reviewed verified by ORBi

Hannon, M., LECHANTEUR, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., BAUDOUX, E., GIET, O., Chantillon, A.-M., Delvenne, P., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (17 June 2014). Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion, 54 (February), 353-363. doi:10.1111/trf.12279
Peer Reviewed verified by ORBi

CAERS, J., WITHOFS, N., Hillengass, J., SIMONI, P., Zamagni, E., HUSTINX, R., & BEGUIN, Y. (April 2014). The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow-up of multiple myeloma. Haematologica, 99 (4), 629-37. doi:10.3324/haematol.2013.091918
Peer Reviewed verified by ORBi

CAERS, J., HAFRAOUI, K., KEUTGENS, A., CABERG, J.-H., LAMBERT, F., TASSIN, F., & BEGUIN, Y. (02 February 2014). Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide. European Journal of Haematology, 92 (2), 179-180. doi:10.1111/ejh.12233
Peer Reviewed verified by ORBi

BRIQUET, A., GREGOIRE, C., Comblain, F., Servais, L., Zeddou, M., LECHANTEUR, C., & Beguin, Y. (2014). Human bone marrow, umbilical cord or liver mesenchymal stromal cells fail to improve liver function in a model of CCl4-induced liver damage in NOD/SCID/IL-2Ry(null) mice. Cytotherapy, 16, 1511-1518. doi:10.1016/j.jcyt.2014.07.003
Peer Reviewed verified by ORBi

Baron, F., Humblet-Baron, S., Ehx, G., SERVAIS, S., HANNON, M., Belle, L., LECHANTEUR, C., BRIQUET, A., GIET, O., BAUDOUX, E., WILLEMS, E., & Beguin, Y. (2014). Thinking out of the box - New approaches to controlling GVHD. Current Hematologic Malignancy Reports, 9, 73-84. doi:10.1007/s11899-013-0187-9
Peer Reviewed verified by ORBi

Duléry, R., Mohty, M., Duhamel, A., Robin, M., BEGUIN, Y., Michallet, M., Vigouroux, S., Lioure, B., Garnier, A., El Cheikh, J., Bulabois, C.-E., Huynh, A., Bay, J.-O., Daguindau, E., Ceballos, P., Clément, L., Dauriac, C., Maillard, N., Legrand, F., ... Yakoub-Agha, I. (2014). Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome : a study from the French Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation, 20, 646-654. doi:10.1016/j.bbmt.2014.01.016
Peer Reviewed verified by ORBi

Binsfeld, M., Beguin, Y., Belle, L., Otjacques, E., HANNON, M., BRIQUET, A., Heusschen, R., Drion, P., Zilberberg, J., Bogen, B., Baron, F., & CAERS, J. (2014). Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation. PLoS ONE, 113764. doi:10.1371/journal.pone.0113764
Peer Reviewed verified by ORBi

Binsfeld, M., Fostier, K., Muller, J., Baron, F., Schots, R., Beguin, Y., Heusschen, R., & CAERS, J. (2014). Cellular immunotherapy in multiple myeloma : lessons from preclinical models. Biochimica et Biophysica Acta - Reviews on Cancer, 1846, 392-404. doi:10.1016/j.bbcan.2014.08.001
Peer Reviewed verified by ORBi

CAERS, J., & BEGUIN, Y. (2014). Le myélome multiple asymptomatique : le paysage thérapeutique change. Oncol. Hematol, 8, 39-45.
Peer reviewed

Belaiche, S., Yafour, N., Balcaen, S., Beguin, Y., Borel, C., Bruno, B., Godin, S., Labussière-Wallet, H., Sanhamut, N., Charbonnier, A., de Berranger, E., Konopacki-Potet, J., Turlure, P., & Yakoub-Agha, I. (2014). Immunosuppresseurs dans la prévention de la réaction du greffon contre l'hôte : rapport de la SFGM-TC. Pathologie Biologie, 62, 197-203. doi:10.1016/j.patbio.2014.05.010
Peer Reviewed verified by ORBi

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2014). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomized trial. Blood, 124, 33-41. doi:10.1182/blood-2014-01-546333
Peer Reviewed verified by ORBi

VANDERMEULEN, M., GREGOIRE, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & DETRY, O. (2014). Rationale for the potential use of mesenchymal stromal cells in liver transplantation. World Journal of Gastroenterology, 20 (44), 16418-32. doi:10.3748/wjg.v20.i44.16418
Peer Reviewed verified by ORBi

Ludwig, H. P., Aapro, M. S., Bokemeyer, C., Glaspy, J. A., Hedenus, M., Littlewood, T. J., Osterborg, A. C., Rzychon, B., Mitchell, D., & BEGUIN, Y. (2014). A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia. Supportive Care in Cancer, 22, 2197-2206. doi:10.1007/s00520-014-2189-0
Peer Reviewed verified by ORBi

LECHANTEUR, C., Baila, S., Janssen, M. E., GIET, O., BRIQUET, A., BAUDOUX, E., & Beguin, Y. (2014). Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks. Journal of Stem Cell Research and Therapy, 4 (8), 1000222. doi:10.4172/2157- 7633.1000222
Peer Reviewed verified by ORBi

Damaj, G., Mohty, M., Robin, M., Michallet, M., Chevallier, P., Beguin, Y., Nguyen, S., Bories, P., Blaise, D., Maillard, N., Rubio, M.-T., Fegueux, N., Cornillon, J., Clavert, A., Huynh, A., Adès, L., Thiébaut-Bertrand, A., Hermine, O., Vigouroux, S., ... Yakoub-Agha, I. (2014). Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome : a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Biology of Blood and Marrow Transplantation, 20, 1349-1355. doi:10.1016/j.bbmt.2014.05.010
Peer Reviewed verified by ORBi

Erpicum, P., DETRY, O., WEEKERS, L., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2014). Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrology Dialysis Transplantation, 29, 1487-1493. doi:10.1093/ndt/gft538
Peer Reviewed verified by ORBi

MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068
Peer Reviewed verified by ORBi

Beguin, Y., & JASPERS, A. (2014). Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. Expert Opinion on Pharmacotherapy, 15, 2087-2103. doi:10.1517/14656566.2014.953928
Peer Reviewed verified by ORBi

CAERS, J., Binsfeld, M., Muller, J., Heusschen, R., & Beguin, Y. (2014). Gammapathie monoclonale de signification indéterminée : information destinée aux médecins référents. Revue Médicale de Liège, 69, 41-46.
Peer reviewed

Beguin, Y., Aapro, M. S., Ludwig, H. P., Mizzen, L., & Osterborg, A. C. (2014). Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis-A critical review. Critical Reviews in Oncology/Hematology, 89, 1-15. doi:10.1016/j.critrevonc.2013.10.008
Peer Reviewed verified by ORBi

Moors, I., Schoemans, H., Callens, S., Beguin, Y., & Kerre, T. (2014). Vaccination guidelines in hematopoietic transplant patients : recommendations from the BHS Transplant Committee. Belgian Journal of Hematology, 6, 44-54.
Peer Reviewed verified by ORBi

Chevallier, P., Labopin, M., Milpied, N., Bilger, K., Socié, G., Yakoub-Agha, I., Michallet, M., Bulabois, C.-E., Maury, S., Beguin, Y., Bay, J.-O., Blaise, D., Maillard, N., Guillerm, G., Daguindeau, E., Raus, N., & Mohty, M. (2014). Outcomes of adults with active or progressive hematological malignancies at time of allogeneic stem cell transplantation : a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 49, 361-365.
Peer Reviewed verified by ORBi

Delforge, M., Selleslag, D., BEGUIN, Y., Triffet, A., Mineur, P., Theunissen, K., Graux, C., Trullemans, F., Boulet, D., Van Eygen, K., Noens, L., Van Steenweghen, S., Lemmens, J., Pierre, P., D'Hondt, R., Ferrant, A., Deeren, D., Van de Velde, A., Wynendaeke, W., ... Ravoet, C. (2014). Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients wih lower risk myelodysplastic syndromes. Leukemia Research, 38, 557-563.
Peer Reviewed verified by ORBi

Battisti, O., & Beguin, Y. (2014). A propos de l'encéphalopathie du nouveau-né. Percentile, 19, 8-9.
Peer reviewed

Bruck, F.* , Belle, L.* , LECHANTEUR, C., de Leval, L., Hannon, M., DUBOIS, S., CASTERMANS, E., Humblet-Baron, S., Rahmouni, S., Beguin, Y., BRIQUET, A.* , & Baron, F.*. (March 2013). Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy, 15 (3), 267-279. doi:10.1016/j.jcyt.2012.09.003
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

JASPERS, A., CAERS, J., LE GAC, G., FEREC, C., BEGUIN, Y., & FILLET, G. (February 2013). A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA). British Journal of Haematology, 160 (4), 564-565. doi:10.1111/bjh.12147
Peer Reviewed verified by ORBi

HAFRAOUI, K., DE PRIJCK, B., & Beguin, Y. (2013). Leucémie myélomonocytaire chronique : diagnostic et thérapeutique. Revue Médicale Suisse, 9, 1512-1517.
Peer Reviewed verified by ORBi

Park, S., Labopin, M., Yakoub-Agha, I., Delaunay, J., Dhedin, N., Deconinck, E., Michallet, M., Robin, M., De Revel, T., Bernard, M., Vey, N., Lioure, B., Lapusan, S., Tabrizi, R., Bourhis, J.-H., Huynh, A., Beguin, Y., Socié, G., Dreyfus, F., ... Mohty, M. (2013). Allogeneic stem cell transplantation for chronic myelomonocytic leukemia : a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. European Journal of Haematology, 90, 355-364. doi:10.1111/ejh.12073
Peer Reviewed verified by ORBi

Otjacques, E., Binsfeld, M., Beguin, Y., Noël, A., Cataldo, D., & CAERS, J. (2013). Aspects biologiques de l'angiogenèse dans le myélome multiple. Oncohématologie, 7 (2), 6-12.
Peer reviewed

Otjacques, E., Binsfeld, M., Rocks, N., Blacher, S., Vanderkerken, K., Noël, A., Beguin, Y., Cataldo, D., & CAERS, J. (2013). Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors. PLoS ONE, 8 (5), 62818. doi:10.1371/journal.pone.0062818
Peer Reviewed verified by ORBi

COLLINS, P., Vijgen, S., DE PRIJCK, B., BLETARD, N., Beguin, Y., & Delvenne, P. (2013). Chimiothérapie, immunodépression et cancers secondaires : rapport d'un cas clinique. Revue Médicale de Liège, 67, 418-422.
Peer reviewed

SERVAIS, S., Beguin, Y., & Baron, F. (2013). Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Emerging Drugs, 18 (2), 173-192. doi:10.1517/14728214.2013.798642
Peer Reviewed verified by ORBi

BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552
Peer Reviewed verified by ORBi

Moermans, C., Poulet, C., HENKET, M., Bonnet, C., WILLEMS, E., Baron, F., Beguin, Y., & Louis, R. (2013). Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respiratory Medicine, 107, 2071-2080. doi:10.1016/j.rmed.2013.10.013
Peer Reviewed verified by ORBi

SERVAIS, S., WILLEMS, E., Beguin, Y., & Baron, F. (2013). Allogreffe de cellules souches hématopoïétiques chez le patient âgé : jusqu'à quel âge ? Revue Médicale de Liège, 68 (1), 38-43.
Peer reviewed

Janssens, A., Lambert, C., Bries, G., Bosly, A., Selleslag, D., & Beguin, Y. (2013). Primary immune thrombocytopenia in adults. Belgian Journal of Hematology, 4 (1), 2-11.
Peer Reviewed verified by ORBi

BRIQUET, A., HALLEUX, A., LECHANTEUR, C., & BEGUIN, Y. (2013). Neuropeptides to replace serum in cryopreservation of mesenchymal stromal cells ? Cytotherapy, 15, 1385-1394. doi:10.1016/j.jcyt.2013.06.012
Peer Reviewed verified by ORBi

Hauzeur, J.-P., Bernard, C., Egrise, D., Kurth, W., Van Cauwenberge, H., LECHANTEUR, C., Gillet, P., Beguin, Y., MALAISE, M., & HUSTINX, R. (2013). (111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fractures. International Orthopaedics, 37 (1), 131-6. doi:10.1007/s00264-012-1719-y
Peer Reviewed verified by ORBi

De Bock, M., Fillet, M., Hannon, M., Seidel, L., Merville, M.-P., Gothot, A., Beguin, Y., & Baron, F. (2013). Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning. PLoS ONE, 8 (2), 55876. doi:10.1371/journal.pone.0055876
Peer Reviewed verified by ORBi

Aapro, M. S., Österborg, A., Gascon, P., Ludwig, H., & Beguin, Y. (2012). Anaemia and cancer : oral or intravenous iron ? Therapeutics, 46-48.
Peer reviewed

Aapro, M. S., Osterborg, A. C., Gascon, P., Ludwig, H. P., & BEGUIN, Y. (2012). Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of intravenous iron. Annals of Oncology, 23, 1954-62.
Peer Reviewed verified by ORBi

FRUSCH, N., SERVAIS, S., DE PRIJCK, B., Corhay, J.-L., Beguin, Y., Louis, R., & DUYSINX, B. (2012). Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis. Acta Clinica Belgica, 67-68. doi:10.2143/ACB.67.5.2062693
Peer Reviewed verified by ORBi

VERTENOEIL, G., SERVAIS, S., & Beguin, Y. (2012). Comment j'explore... une fièvre d'origine indéterminée chez le patient adulte ? Revue Médicale de Liège, 67 (7-8), 391-397.
Peer reviewed

Roelants, V., DELGAUDINE, M., Walrand, S., Lhommel, R., Beguin, Y., Jamar, F., & Vanoverschelde, J.-L. (2012). Myocardial infarct size quantification in mice by SPECT using a novel algorithm independent of a normal perfusion database. EJNMMI Research, 2, 64-75. doi:10.1186/2191-219X-2-64
Peer Reviewed verified by ORBi

Damaj, G., Duhamel, A., Robin, M., Beguin, Y., Michallet, M., Mohty, M., Vigouroux, S., Bories, P., Garnier, A., El Cheikh, J., Bulabois, C.-E., Huynh, A., Bay, J.-O., Legrand, F., Deconinck, E., Fegueux, N., Clement, L., Dauriac, C., Maillard, N., ... Yakoub-Agha, I. (2012). Impact of Azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes : a study b the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe Francophone des Myélodysplasies. Journal of Clinical Oncology, 30, 4533-4540. doi:10.1200/JCO.2012.44.3499
Peer Reviewed verified by ORBi

Verbeke, N., Beguin, Y., Wildiers, H., Canon, J.-L., Bries, G., Bosly, A., & Van Belle, S. (2012). High prevalence of anaemia and limited use of therapy in cancer patients : a Belgian survey (Anaemia Day 2008). Supportive Care in Cancer, 20, 23-28. doi:10.1007/s00520-010-1045-0
Peer Reviewed verified by ORBi

Belle, L., Bruck, F., FOGUENNE, J., GOTHOT, A., BEGUIN, Y., Baron, F., & Briquet, A. (2012). Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34+ Cells. PLoS ONE, 7 (12), 52564. doi:10.1371/journal.pone.0052564
Peer Reviewed verified by ORBi

Kermani, H., Goffinet, L., Mottet, M., Bodart, G., Morrhaye, G., Dardenne, O., Overbergh, L., Baron, F., Beguin, Y., Geenen, V., & Martens, H. (2012). Expression of growth hormone (GH)/insulin-like growth factor (IGF) axis during Balb/c ontogeny and effects of GH upon ex-vivo T-cell differentiation. Neuroimmunomodulation, 19, 137-147.
Peer Reviewed verified by ORBi

Huybrechts, S., BEGUIN, Y., Bordon, V., DRESSE, M.-F., Dupont, S., Ferster, A., Laureys, G., Meyts, I., Renard, M., & Vermylen, C. (2012). Less veno-occlusive disease after intravenous versus oral busulfan for autologous haematopoietic stem cell transp.l antation: the Belgian paediatric experlence. Belgian Journal of Hematology, 3 (2), 34-40.
Peer Reviewed verified by ORBi

Malaise, O., FRUSCH, N., BECK, E., Servais, S., BETEA, D., CAERS, J., DE PRIJCK, B., & BEGUIN, Y. (2012). Panhypopituitarism and diabetus insipidus in a patient with primary central nervous system lymphoma. Leukemia and Lymphoma, 53 (12), 2515-16.
Peer Reviewed verified by ORBi

VANDAMME, A., Schots, R., & BEGUIN, Y. (2012). Academic clinical trials run by the transplant committee of the Belgian Hematological Society. Belgian Journal of Hematology, 3 (2), 62-67.
Peer Reviewed verified by ORBi

Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90.
Peer Reviewed verified by ORBi

Zeddou, M., RELIC, B., MALAISE, O., CHARLIER, E., Desouroux, A., BEGUIN, Y., DE SENY, D., & Malaise, M. (2012). Differential signalling through ALK-1 and ALK-5 regulates leptin expression in Mesenchymal Stem Cells. Stem Cells and Development, 21 (11), 1948-54. doi:10.1089/scd.2011.0321
Peer Reviewed verified by ORBi

Noterdaeme, T., Longree, L., Bataille, C., DE ROOVER, A., LAMPROYE, A., DELWAIDE, J., Beguin, Y., Honoré, P., & DETRY, O. (July 2011). Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patients. World Journal of Gastroenterology, 17 (25), 3069-72. doi:10.3748/wjg.v17.i25.3069
Peer Reviewed verified by ORBi

SERVAIS, S., Baron, F., & Beguin, Y. (2011). Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning. Transfusion and Apheresis Science, 44, 205-210. doi:10.1016/j.transci.2011.01.019
Peer Reviewed verified by ORBi

Otjacques, E., Binsfeld, M., Noël, A., Beguin, Y., Cataldo, D., & CAERS, J. (2011). Biological aspects of angiogenesis in multiple myeloma. International Journal of Hematology, 94 (6), 505-18. doi:10.1007/s12185-011-0963-z
Peer Reviewed verified by ORBi

CAERS, J., BONNET, C., GRAUX, C., DE PRIJCK, B., & BEGUIN, Y. (2011). Prise en charge actuelle des syndromes myélodysplasiques. Revue Médicale Suisse, 7, 1634-1643.
Peer Reviewed verified by ORBi

Robin, M., Sanz, G. F., Ionescu, I., Rio, B., Sirvent, A., Renaud, M., Carreras, E., Milpied, N., Mohty, M., Beguin, Y., Bordigoni, P., De Witte, T., Picardi, A., Purtill, D., Gluckman, E., Kroger, N., & Rocha, V. (2011). Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia : a survey on behalf of Eurocord and CLWP of EBMT. Leukemia, 25, 75-81. doi:10.1038/leu.2010.219
Peer Reviewed verified by ORBi

Bonnet, C., CAERS, J., DE PRIJCK, B., HAFRAOUI, K., & Beguin, Y. (2011). Lymphome du manteau : prise en charge 2011. Revue Médicale Suisse, 7, 1644-1649.
Peer Reviewed verified by ORBi

DELGAUDINE, M., Lambermont, B., Lancellotti, P., Roelants, V., Walrand, S., Vanoverschelde, J.-L., Pierard, L., Gothot, A., & Beguin, Y. (2011). Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal mice. Cytotherapy, 13, 237-247. doi:10.3109/14653249.2010.491820
Peer Reviewed verified by ORBi

CASTERMANS, E., Hannon, M., Dutrieux, J., Humblet, S., Seidel, L., Cheynier, R., Willems, E., Gothot, A., Vanbellinghen, J.-F., Geenen, V., Sandmaier, B. M., Storb, R., Beguin, Y., & Baron, F. (2011). Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age. Haematologica, 96(2), 298-306. doi:10.3324/haematol.2010.029702
Peer Reviewed verified by ORBi

Servais, S., Beguin, Y., & Baron, F. (2011). Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT). Belgian Journal of Hematology, 2, 3-9.
Peer Reviewed verified by ORBi

Aapro, M. S., Beguin, Y., Birgegard, G., Gascon, P., Hedenus, M., & Osterborg, A. (2011). Too low iron doses and too many dropouts in negative iron trial. Journal of Clinical Oncology, 525-e526. doi:10.1200/JCO.2011.35.3219
Peer Reviewed verified by ORBi

Servais, S., Willems, E., Beguin, Y., & Baron, F. (2010). Maladie du greffon contre l'hôte chronique : une prise en charge multidisciplinaire. Revue Médicale de Liège, 65, 81-87.
Peer reviewed

Roufosse, R., & Beguin, Y. (2010). Observance thérapeutique en hématologie : le cas particulier de la leucémie myéloïde chronique. Revue Médicale de Liège, 65, 409-412.
Peer reviewed

Dirix, L., Awada, A., Bron, D., Canon, J.-L., De Grève, J., Humblet, Y., Peeters, M., Van Belle, S., Vansteenkiste, J., Beguin, Y., & Vermorken, J. (2010). Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia. Belgian Journal of Medical Oncology, 4, 57-64.
Peer Reviewed verified by ORBi

Willems, E.* , Baron, F.* , Seidel, L., Frère, P., Fillet, G., & Beguin, Y. (2010). Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 689-693. doi:10.1038/bmt.2009.230
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Delgaudine, M., Gothot, A., & Beguin, Y. (2010). Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction. Cytotherapy, 12 (7), 909-18. doi:10.3109/14653240903580262
Peer Reviewed verified by ORBi

Briquet, A., Dubois, S., Bekaert, S., Dolhet, M., Beguin, Y., & Gothot, A. (2010). Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID -repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica, 95 (1), 47-56. doi:10.3324/haematol.2009.008524
Peer Reviewed verified by ORBi

Willems, E., Humblet-Baron, S., Dengis, O., Seidel, L., Beguin, Y., & Baron, F. (2010). Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 1442-1448. doi:10.1038/bmt.2009.360
Peer Reviewed verified by ORBi

Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011
Peer Reviewed verified by ORBi

Zeddou, M., Briquet, A., Relic, B., Josse, C., Malaise, M., Gothot, A., Lechanteur, C., & Beguin, Y. (2010). The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biology International, 34 (7), 693-701. doi:10.1042/CBI20090414
Peer Reviewed verified by ORBi

Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176.
Peer reviewed

Baron, F., & Beguin, Y. (2010). Hematopoietic stem cell transplantation in the treatment strategy of acute leukemia. Belgian Journal of Medical Oncology, 4, 118-123.
Peer Reviewed verified by ORBi

Servais, S., Caers, J., Warling, O., Frusch, N., Baron, F., De Prijck, B., & Beguin, Y. (2010). Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma. British Journal of Haematology, 150 (3), 379-381. doi:10.1111/j.1365-2141.2010.08202.x
Peer Reviewed verified by ORBi

Hafraoui, K., Beguin, Y., & Baron, F. (2009). Cancers secondaires après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (10), 496-499.
Peer reviewed

Willems, E., Canivet, J.-L., Ghaye, B., de Leval, L., Radermecker, M., Preiser, J.-C., & Beguin, Y. (2009). Pulmonary veno-occlusive disease in myeloproliferative disorder. European Respiratory Journal, 33 (1), 213-216. doi:10.1183/09031936.00157707
Peer Reviewed verified by ORBi

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.
Peer reviewed

Avivi, I., Montoto, S., Canals, C., Maertens, J., Al-Ali, H., Mufti, G. J., Finke, J., Schattenberg, A., Fanin, R., Cornelissen, J. J., Vernant, J.-P., Russel, N., Beguin, Y., Thomason, K., Verdonck, L. F., Kobbe, G., Tilly, H., Socié, G., & Sureda, A. (2009). Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma : an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. British Journal of Haematology, 147, 719-728. doi:10.1111/j.1365-2141.2009.07905.x
Peer Reviewed verified by ORBi

Castermans, E., Hannon, M., Drion, P., Geenen, V., Beguin, Y., & Baron, F. (2009). Reconstitution du système immunitaire après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (S1), 2-8.
Peer reviewed

Foguenne, J., Di Stefano, Giet, O., Beguin, Y., & Gothot, A. (2009). Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice. Haematologica, 94, 185-194. doi:10.3324/haematol.13206
Peer Reviewed verified by ORBi

Beguin, Y. (2009). Utilisation thérapeutique de l'érythropoïétine. Revue du Praticien, 59, 82-83.
Peer reviewed

Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7.
Peer Reviewed verified by ORBi

Dugauquier, C., Bataille, Y., Willems, E., Frere, P., De Prijck, B., Beguin, Y., & Baron, F. (2009). Toxoplasmore cérébrale compliquant une mini-allogreffe de cellules souches hématopoïétiques du sang périphérique. Revue Médicale de Liège, 64 (7-8), 366-369.
Peer reviewed

Relic, B., Zeddou, M., Desoroux, A., Beguin, Y., De Seny, D., & Malaise, M. (2009). Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Laboratory Investigation, 89 (7), 811-822. doi:10.1038/labinvest.2009.41
Peer Reviewed verified by ORBi

Morrhaye, G., Kermani, H., Legros, J.-J., Baron, F., Beguin, Y., Moutschen, M., Cheynier, R., Martens, H., & Geenen, V. (2009). Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE, 4 (5), 5668. doi:10.1371/journal.pone.0005668
Peer Reviewed verified by ORBi

Willemze, R., Rodrigues, C. A., Labopin, M., Sanz, G., Michel, G., Socié, G., Rio, B., Sirvent, A., Renaud, M., Madero, L., Mothy, M., Ribera, J. M., Garnier, F., Garcia, J., Lecchi, L., Kögler, G., Beguin, Y., Navarette, C., Boogaerts, M., ... Rocha, V. (2009). KIR-ligand incompatibility in the Graft-versus-host direction improves outcome after umbilical cord blood transplantation for acute leukemia. Leukemia, 23, 492-500. doi:10.1038/leu.2008.365
Peer Reviewed verified by ORBi

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Hoyoux, C., Dresse, M.-F., Robinet, S., Forget, P., Pieltain, C., Ketelslegers, O., & Beguin, Y. (2008). Cord blood transplantation in a child with Pearson's disease. Pediatric Blood and Cancer, 51 (4), 566. doi:10.1002/pbc.21615
Peer Reviewed verified by ORBi

Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63.
Peer reviewed

Brand, A., Rebulla, P., Engelfriet, C. P., Reesink, H. W., Beguin, Y., Baudoux, E., Kögler, G., Ebrahimi, M., Grazzini, G., Costa, A. N., Bosi, A., Sacchi, S., Lombardini, L., Pupella, S., Lecchi, L., Calderon Garciduenas, E. D., van Beckhoven, J. M., de Wit, H. J. C., Fibbe, W. E., ... Regan, F. (2008). Cord blood banking. Vox Sanguinis, 95, 335-348. doi:10.1111/j.1423-0410.2008.01106.x
Peer Reviewed verified by ORBi

Beguin, Y. (2008). Le sang de cordon ombilical. Revue du Praticien, 58, 2107-08.
Peer reviewed

Castermans, E.* , Baron, F.* , Willems, E., Schaaf-Lafontaine, N., Meuris, N., Gothot, A., Vanbellinghen, J.-F., Herens, C., Seidel, L., Geenen, V., Cheynier, R., & Beguin, Y. (2008). Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. Haematologica, 93 (2), 240-7. doi:10.3324/haematol.11708
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Bovy, C., Gothot, A., Krzesinski, J.-M., Warling, X., & Beguin, Y. (20 January 2007). Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrology Dialysis Transplantation, 11, 1156-1162. doi:10.1093/ndt/gfl765
Peer Reviewed verified by ORBi

De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90.
Peer reviewed

Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Geenen, V., Beguin, Y., & Baron, F. (2007). Evaluation de la thymopoiese: applications cliniques. Revue Médicale de Liège, 62 (12), 725-9.
Peer reviewed

Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Baron, F., Beguin, Y., & Geenen, V. (2007). Evaluation clinique de la fonction du thymus. Revue Médicale de Liège, 62 (11), 675-8.
Peer reviewed

Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x
Peer Reviewed verified by ORBi

Cavill, I., Auerbach, M., Bailie, G. R., Barrett-Lee, P., Beguin, Y., Kaltwasser, P., Littlewood, T., Macdougall, I. C., & Wilson, K. (2006). Iron and the anaemia of chronic disease: a review and strategic recommendations. Current Medical Research and Opinion, 22 (4), 731-7. doi:10.1185/030079906X100096
Peer Reviewed verified by ORBi

Bovy, C., Baudoux, E., Salmon, J., & Beguin, Y. (2006). Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Transfusion, 46 (9), 1616-23. doi:10.1111/j.1537-2995.2006.00945.x
Peer Reviewed verified by ORBi

Van Overstraeten-Schlogel, N., Beguin, Y., & Gothot, A. (2006). Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. European Journal of Haematology, 76 (6), 488-93. doi:10.1111/j.1600-0609.2006.00633.x
Peer Reviewed verified by ORBi

Van Overstraeten-Schlogel, N., Delgaudine, M., Beguin, Y., & Gothot, A. (2006). Limitations of the use of GFP transgenic mice in bone marrow transplantation studies. Leukemia and Lymphoma, 47 (7), 1392-3. doi:10.1080/10428190500513512
Peer Reviewed verified by ORBi

Jerusalem, G., & Beguin, Y. (2006). The place of positron emission tomography imaging in the management of patients with malignant lymphoma. Haematologica, 91 (4), 442-4.
Peer Reviewed verified by ORBi

Pirson, L.* , Baron, F.* , Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2006). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice. Stem Cells, 24 (7), 1814-21. doi:10.1634/stemcells.2005-0290
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Baron, F., Vanstraelen, G., & Beguin, Y. (2006). Transfusions after nonmyeloablative or reduced-intensity conditioning regimens. Leukemia, 20 (12), 2081-6. doi:10.1038/sj.leu.2404431
Peer Reviewed verified by ORBi

Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012
Peer reviewed

Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255
Peer Reviewed verified by ORBi

Frere, P., Pereira-Martins, M., Fillet, G., & Beguin, Y. (2006). Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. European Journal of Haematology, 76 (2), 102-8. doi:10.1111/j.1600-0609.2005.00569.x
Peer Reviewed verified by ORBi

Vanstraelen, G., Frere, P., Ngirabacu, M.-C., Willems, E., Fillet, G., & Beguin, Y. (2006). Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. Experimental Hematology, 34 (3), 382-8. doi:10.1016/j.exphem.2005.11.013
Peer reviewed

Glaspy, J., & Beguin, Y. (2005). Anaemia management strategies: optimising treatment using epoetin beta (NeoRecormon). Oncology, 69 Suppl 2, 8-16. doi:10.1159/000088283
Peer Reviewed verified by ORBi

Bataille, Y., Bovy, C., Lancellotti, P., Melchior, V., Delbecque, K., Beguin, Y., & Krzesinski, J.-M. (2005). Primary amyloidosis (AL) as a cause of nephrotic syndrome. Acta Clinica Belgica, 60 (2), 94-7. doi:10.1179/acb.2005.017
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Evaluation of therapy for lymphoma. Seminars in Nuclear Medicine, 35 (3), 186-96. doi:10.1053/j.semnuclmed.2005.02.004
Peer Reviewed verified by ORBi

Bovy, C., Gothot, A., Krzesinski, J.-M., & Beguin, Y. (2005). Mature erythrocyte indices: new markers of iron availability. Haematologica, 90 (4), 549-51.
Peer Reviewed verified by ORBi

Piette, C., Dresse, M.-F., Forget, P., Schmitz, V., Demarche, M., Erpicum, P., Closon, M.-T., Rutten, I., Paulus, P., Vivegnis, D., Beguin, Y., Jamblin, P., & Hoyoux, C. (2005). Les neuroblastomes de l'enfant. A propos de 23 cas. Revue Médicale de Liège, 60 (3), 173-80.
Peer reviewed

Vanstraelen, G., Baron, F., Frere, P., Hafraoui, K., Fillet, G., & Beguin, Y. (2005). Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation. Haematologica, 90 (9), 1269-70.
Peer Reviewed verified by ORBi

Willems, E., Baron, F., Vanstraelen, G., Frere, P., Fillet, G., & Beguin, Y. (2005). Immunotherapie du cancer par minigreffe de cellules souches hematopoietiques. Revue Médicale Suisse, 1 (30), 1973-7.
Peer Reviewed verified by ORBi

Beguin, Y. (2005). Intravenous iron and recombinant human erythropoietin in cancer patients. Journal of Clinical Oncology, 23 (3), 651-2; author reply 652-3. doi:10.1200/JCO.2005.05.184
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Positron emission tomography imaging for lymphoma. Current Opinion in Oncology, 17 (5), 441-5. doi:10.1097/01.cco.0000174041.29557.5c
Peer Reviewed verified by ORBi

Foguenne, J., Huygen, S., Greimers, R., Beguin, Y., & Gothot, A. (2005). Modulation of homing properties of primitive progenitor cells generated by ex vivo expansion. Haematologica, 90 (4), 445-51.
Peer Reviewed verified by ORBi

T'Sjoen, G., Beguin, Y., Feyen, E., Rubens, R., Kaufman, J.-M., & Gooren, L. (2005). Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. Journal of Endocrinology, 186 (1), 61-7. doi:10.1677/joe.1.06112
Peer Reviewed verified by ORBi

Bovy, C., Krzesinski, J.-M., Gothot, A., & Beguin, Y. (2004). Impact of erythropoietic activity on red cell parameters in chronic renal failure patients. Haematologica, 89 (6), 748-9.
Peer Reviewed verified by ORBi

Beguin, Y., & Weber, G. (2004). Serum selenium in lymphoma. Journal of Clinical Oncology, 22 (16), 3429; author reply 3430. doi:10.1200/JCO.2004.99.240
Peer Reviewed verified by ORBi

Frere, P., Hermanne, J.-P., Debouge, M.-H., De Mol, P., Fillet, G., & Beguin, Y. (2004). Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplantation, 33 (7), 745-9. doi:10.1038/sj.bmt.1704414
Peer Reviewed verified by ORBi

Baron, F., Copizza, S., Baudoux, E., Jerusalem, G., Fillet, G., & Beguin, Y. (2004). CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer. Haematologica, 89 (9), 1146-8.
Peer Reviewed verified by ORBi

Passweg, J. R., Rabusin, M., Musso, M., Beguin, Y., Cesaro, S., Ehninger, G., Espigado, I., Iriondo, A., Jost, L., Koza, V., Lenhoff, S., Lisukov, I., Locatelli, F., Marmont, A., Philippe, Pilatrino, C., Quartier, P., Stary, J., Veys, P., ... Gratwohl, A. (2004). Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. British Journal of Haematology, 125 (6), 749-55. doi:10.1111/j.1365-2141.2004.04978.x
Peer Reviewed verified by ORBi

Willems, E., Valdes Socin, H. G., Betea, D., Beckers, A., & Beguin, Y. (September 2003). Association of acute leukemia and autoimmune polyendocrine syndrome in two kindreds. Leukemia, 17 (9), 1912-1914. doi:10.1038/sj.leu.2403064
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., Depas, G., Fassotte, M.-F., De Barsy, C., Foidart, J., & Fillet, G. (2003). Les lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 27 (8), 401-410.
Peer reviewed

Cazzola, M., Beguin, Y., Kloczko, J., Spicka, I., & Coiffier, B. (2003). Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production. British Journal of Haematology, 122 (3), 386-93. doi:10.1046/j.1365-2141.2003.04439.x
Peer Reviewed verified by ORBi

Baron, F., DRESSE, M.-F., & Beguin, Y. (2003). Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation. New England Journal of Medicine, 349 (9), 913-4. doi:10.1056/NEJM200308283490921
Peer Reviewed verified by ORBi

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003). Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Annals of Oncology, 14 (1), 123-30. doi:10.1093/annonc/mdg011
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. Clinical Cancer Research, 9 (15), 5566-72.
Peer Reviewed verified by ORBi

Baron, F., Frere, P., & Beguin, Y. (2003). Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment. Haematologica, 88 (6), 718-20.
Peer Reviewed verified by ORBi

Schetelig, J., Fetscher, S., Reichle, A., Berdel, W. E., Beguin, Y., Brunet, S., Caballero, D., Majolino, I., Hagberg, H., Johnsen, H. E., Kimby, E., Montserrat, E., Stewart, D., Copplestone, A., Rosler, W., Pavel, J., Kingreen, D., & Siegert, W. (2003). Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica, 88 (11), 1272-8.
Peer Reviewed verified by ORBi

Andre, M., Baudoux, E., Bron, D., Canon, J.-L., D'Hondt, V., Fassotte, M.-F., D'Hondt, L., Fillet, G., Humblet, Y., Jerusalem, G., Vermeulen, P., Symann, M., & Beguin, Y. (2003). Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion, 43 (1), 50-7. doi:10.1046/j.1537-2995.2003.00273.x
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2003). PET scan imaging in oncology. European Journal of Cancer, 39 (11), 1525-34. doi:10.1016/S0959-8049(03)00374-5
Peer Reviewed verified by ORBi

Canivet, J.-L., Yans, T., Piret, S., Frere, P., & Beguin, Y. (2003). Barotrauma-induced tension pneumoperitoneum. Acta Anaesthesiologica Belgica, 54 (3), 233-6.
Peer Reviewed verified by ORBi

Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2003). Binding and migration across fibronectin and VCAM-1 of cycling hematopoietic progenitor cells. Leukemia and Lymphoma, 44 (8), 1379-83. doi:10.1080/1042819031000083406
Peer Reviewed verified by ORBi

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion. British Journal of Haematology, 123 (1), 103-5. doi:10.1046/j.1365-2141.2003.04556.x
Peer Reviewed verified by ORBi

Humblet-Baron, S., Baron, F., Chachati, A., Bury, J., Morelon, E., Kreis, H., & BEGUIN, Y. (2003). Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia. Transplantation, 76 (10), 1531-2. doi:10.1097/01.TP.0000085285.59061.D7
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80.
Peer Reviewed verified by ORBi

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7
Peer Reviewed verified by ORBi

Hafraoui, K., Humblet-Baron, S., Baron, F., Beguin, Y., & Fillet, G. (2003). Comment je traite ... la leucemie myeloide chronique (LMC). Revue Médicale de Liège, 58 (1), 7-12.
Peer reviewed

Beguin, Y., & Baron, F. (2003). Minitransplants: allogeneic stem cell transplantation with reduced toxicity. Acta Clinica Belgica, 58 (1), 37-45. doi:10.1179/acb.2003.58.1.005
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7.
Peer Reviewed verified by ORBi

Beguin, Y. (2003). Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clinica Chimica Acta, 329 (1-2), 9-22. doi:10.1016/S0009-8981(03)00005-6
Peer Reviewed verified by ORBi

Humblet-Baron, S., Baron, F., Pirson, L., Beguin, Y., & Fillet, G. (28 August 2002). Traitement moléculaire du cancer: le STI571, un inhibiteur des tyrosines kinases. Revue Médicale Suisse, 60 (598), 1504-1508.
Peer Reviewed verified by ORBi

Verhoef, H., West, C. E., Veenemans, J., Beguin, Y., & Kok, F. J. (2002). Stunting may determine the severity of malaria-associated anemia in African children. Pediatrics, 110 (4), 48. doi:10.1542/peds.110.4.e48
Peer Reviewed verified by ORBi

Jerusalem, G., & Beguin, Y. (2002). Does positron emission tomography have a role in routine clinical practice in patients with Hodgkin's disease? Clinical Lymphoma, 3 (2), 125-6. doi:10.1016/S1526-9655(11)70258-5
Peer Reviewed verified by ORBi

Baron, F., & Beguin, Y. (2002). Nonmyeloablative allogeneic hematopoietic stem cell transplantation. Journal of Hematotherapy and Stem Cell Research, 11 (2), 243-63. doi:10.1089/152581602753658448
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Herens, C., Fillet, G., & Beguin, Y. (2002). Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML. Haematologica, 87 (12), 43.
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2002). The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Annals of Oncology, 13 Suppl 4, 227-34. doi:10.1093/annonc/mdf664
Peer Reviewed verified by ORBi

Jerusalem, G., & Beguin, Y. (2002). Commentary on "Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?". Clinical Lymphoma, 2 (4), 249. doi:10.1016/S1526-9655(11)70232-9
Peer Reviewed verified by ORBi

Giet, O., Van Bockstaele, D. R., Di Stefano, I., Huygen, S., Greimers, R., Beguin, Y., & Gothot, A. (2002). Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells. Blood, 99 (6), 2023-31. doi:10.1182/blood.V99.6.2023
Peer Reviewed verified by ORBi

Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6
Peer reviewed

Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2002). Modulation par le cycle cellulaire de l'implantation des cellules souches hématopoïétiques. Hématologie, 8, 397-404.
Peer reviewed

Baron, F., & Beguin, Y. (2002). Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 8 (7), 351-9. doi:10.1053/bbmt.2002.v8.pm12171481
Peer Reviewed verified by ORBi

Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84.
Peer reviewed

Jerusalem, G., & Beguin, Y. (2002). Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Clinical Lymphoma, 3 (1), 56-61. doi:10.3816/CLM.2002.n.012
Peer Reviewed verified by ORBi

Frere, P., Hermanne, J.-P., Debouge, M.-H., Fillet, G., & Beguin, Y. (2002). Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation, 29 (7), 589-94. doi:10.1038/sj/bmt/1703413
Peer Reviewed verified by ORBi

Beguin, Y. (2002). Le métabolisme du fer. Hématologie, 8, 7-S11.
Peer reviewed

Huygen, S., Giet, O., Artisien, V., Di Stefano, I., Beguin, Y., & Gothot, A. (2002). Adhesion of synchronized human hematopoietic progenitor cells to fibronectin and vascular cell adhesion molecule-1 fluctuates reversibly during cell cycle transit in ex vivo culture. Blood, 100 (8), 2744-52. doi:10.1182/blood.V100.8.2744
Peer Reviewed verified by ORBi

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484
Peer Reviewed verified by ORBi

Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.-P., Fillet, G., & Beguin, Y. (2002). Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. Haematologica, 87 (1), 78-88.
Peer Reviewed verified by ORBi

Baron, F., Baudoux, E., Fillet, G., & Beguin, Y. (2002). Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation. Hematology, 7 (3), 137-43. doi:10.1080/1024533021000008173
Peer Reviewed verified by ORBi

Beguin, Y. (2002). Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients. Haematologica, 87 (11), 1209-21.
Peer Reviewed verified by ORBi

Beguin, Y., Benoit, Y., Crokaert, F., Selleslag, D., & Vandercam, B. (2002). Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel. Acta Clinica Belgica, 57 (6), 309-16. doi:10.1179/acb.2002.058
Peer Reviewed verified by ORBi

Engelfriet, C. P., Reesink, H. W., Wagner, J. E., Kogler, G., Rocha, V., Wernet, P., Lecchi, L., Lazzari, L., Ratti, I., Giovanelli, S., Poli, F., Rebulla, P., Beguin, Y., Baudoux, E., Navarrete, C., Armitage, S., Laughlin, M. J., & McClelland, W. M. (2002). International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sanguinis, 83 (2), 172-87. doi:10.1046/j.1423-0410.2002.00197.x
Peer Reviewed verified by ORBi

Baron, F., Fillet, G., & Beguin, Y. (2002). Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation. Transplantation, 74 (12), 1692-6. doi:10.1097/00007890-200212270-00008
Peer Reviewed verified by ORBi

Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M.-F., Rigo, P., & Fillet, G. (2001). Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of Oncology, 12 (6), 825-30. doi:10.1023/A:1011169332265
Peer Reviewed verified by ORBi

Sylvestre, R.-M., Jerusalem, G., Sautois, B., Beguin, Y., & Fillet, G. (2001). Nouvelles approches thérapeutiques puor l'hypernéphrome métastasique. Médecine et Hygiène, 59, 1607-1609.
Peer Reviewed verified by ORBi

Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18.
Peer Reviewed verified by ORBi

Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442
Peer Reviewed verified by ORBi

Paquet, P., Arrese Estrada, J., Beguin, Y., & Pierard, G. (2001). Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction. Current Topics in Pathology. Ergebnisse der Pathologie, 94, 49-63. doi:10.1007/978-3-642-59552-3_3
Peer Reviewed verified by ORBi

Giet, O., Huygen, S., Beguin, Y., & Gothot, A. (2001). Cell cycle activation of hematopoietic progenitor cells increases very late antigen-5-mediated adhesion to fibronectin. Experimental Hematology, 29 (4), 515-24. doi:10.1016/S0301-472X(00)00682-2
Peer reviewed

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2001). Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571. Haematologica, 86 (9), 993-4.
Peer Reviewed verified by ORBi

Beguin, Y. (2001). Intérêt du dosage du récepteur soluble de la transferrine (sTfR) pour l'évaluation de l'érythropoïèse et de l'état du fer. Hématologie, 7, 161-169.
Peer reviewed

R'Zik, S., Loo, M., & Beguin, Y. (2001). Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels. Haematologica, 86 (3), 244-51.
Peer Reviewed verified by ORBi

R'Zik, S., & Beguin, Y. (2001). Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Experimental Hematology, 29 (6), 677-85. doi:10.1016/S0301-472X(01)00641-5
Peer reviewed

Verhoef, H., West, C. E., Ndeto, P., Burema, J., Beguin, Y., & Kok, F. J. (2001). Serum transferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria. American Journal of Clinical Nutrition, 74 (6), 767-75. doi:10.1093/ajcn/74.6.767
Peer Reviewed verified by ORBi

Jerusalem, G., Belhocine, T., Silvestre, R.-M., Sautois, B., Hustinx, R., Beguin, Y., Fillet, G., & Rigo, P. (2001). Place de la tomographie d'émission de positons dans le suivi thérapeutique du cancer du sein. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 25 (6), 341-346.
Peer reviewed

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001). Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica, 86 (3), 266-73.
Peer Reviewed verified by ORBi

Fillet, G., & Beguin, Y. (2001). Monitoring of erythropoiesis by the serum transferrin receptor and erythropoietin. Acta Clinica Belgica, 56 (3), 146-54. doi:10.1179/acb.2001.024
Peer Reviewed verified by ORBi

JERUSALEM, G., & BEGUIN, Y. (June 2000). Commentary on "Positron emission tomography in lymphoma : comparison with computed tomography and Gallium-67 single photon emission computed tomography imaging". Clinical Lymphoma, 1 (1), 75-76.
Peer Reviewed verified by ORBi

Magee, L. A., von Dadelszen, P., Darley, J., & Beguin, Y. (2000). Erythropoiesis and renal transplant pregnancy. Clinical Transplantation, 14 (2), 127-35. doi:10.1034/j.1399-0012.2000.140205.x
Peer Reviewed verified by ORBi

Roodenburg, A. J., West, C. E., Beguin, Y., Van Dijk, J. E., Van Eijk, H. G., Marx, J. J., & Beynen, A. C. (2000). Indicators of erythrocyte formation and degradation in rats with either vitamin A or iron deficiency. Journal of Nutritional Biochemistry, 11 (4), 223-30. doi:10.1016/S0955-2863(00)00070-X
Peer Reviewed verified by ORBi

Frere, P., Canivet, J.-L., Gennigens, C., Rebeix, J. P., Fillet, G., & Beguin, Y. (2000). Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplantation, 26 (3), 343-5. doi:10.1038/sj.bmt.1702485
Peer Reviewed verified by ORBi

Tassin, F., Dewé, W., Schaaf-Lafontaine, N., Herens, C., Ravoet, C., Albert, A., Beguin, Y., & Paulus, J.-M. (2000). A four-parameter index of marrow dysplasia has predictive value for survival in myelodysplastic syndromes. Leukemia and Lymphoma, 36 (5-6), 485-96. doi:10.3109/10428190009148396
Peer Reviewed verified by ORBi

Fraipont, V., Sautois, B., Baudoux, E., Pereira-Martins, M., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Longree, L., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2000). Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF. Transfusion, 40 (3), 339-47. doi:10.1046/j.1537-2995.2000.40030339.x
Peer Reviewed verified by ORBi

Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Desouter-Lecomte, M., DE PRIJCK, B., Longree, L., & Koulischer, L. (2000). Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. British Journal of Haematology, 110 (1), 214-6. doi:10.1046/j.1365-2141.2000.02142.x
Peer Reviewed verified by ORBi

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2000). Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica, 85 (6), 613-8.
Peer Reviewed verified by ORBi

Baron, F., Gothot, A., Salmon, J., Hermanne, J. P., Pierard, G., Fillet, G., & Beguin, Y. (2000). Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. British Journal of Haematology, 111 (3), 745-53. doi:10.1046/j.1365-2141.2000.02470.x
Peer Reviewed verified by ORBi

Jerusalem, G., & Beguin, Y. (2000). Clinical impact and perspectives of 18F-FDG PET in lymphoma. Clinical Lymphoma, 1, 75-76.
Peer Reviewed verified by ORBi

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Najjar, F., Hustinx, R., Rigo, P., & Fillet, G. (2000). Evaluation thérapeutique précoce par tomographie à émission de positons. Médecine et Hygiène, 58, 1629-1632.
Peer Reviewed verified by ORBi

Sautois, B., Scerbo, F., Beguin, Y., & Fillet, G. (2000). Traitement des myélomes réfractaires par la Thalidomide. Médecine et Hygiène, 58, 1633-1634.
Peer Reviewed verified by ORBi

Baron, F., & Beguin, Y. (2000). Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation. Transfusion, 40 (4), 468-76. doi:10.1046/j.1537-2995.2000.40040468.x
Peer Reviewed verified by ORBi

Baron, F., Dresse, M.-F., & Beguin, Y. (2000). Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease. Transfusion, 40 (9), 1071-3. doi:10.1046/j.1537-2995.2000.40091071.x
Peer Reviewed verified by ORBi

Ribbens, C., Bonnet, V., Kaiser, M.-J., Andre, B., Kaye, O., Franchimont, N., De Groote, D., Beguin, Y., & Malaise, M. (2000). Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clinical and Experimental Immunology, 120 (1), 194-199. doi:10.1046/j.1365-2249.2000.01198.x
Peer Reviewed verified by ORBi

Baron, F., Ribbens, C., Kaye, O., Fillet, G., Malaise, M., & Beguin, Y. (2000). Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. British Journal of Haematology, 110 (2), 339-342. doi:10.1046/j.1365-2141.2000.02191.x
Peer Reviewed verified by ORBi

Loo, M., & Beguin, Y. (1999). The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood, 93 (10), 3286-93. doi:10.1182/blood.v93.10.3286.410k29_3286_3293
Peer Reviewed verified by ORBi

Bovy, C., Tsobo, C., Crapanzano, L., Rorive, G., Beguin, Y., Albert, A., & Paulus, J.-M. (1999). Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney International, 56 (3), 1113-9. doi:10.1046/j.1523-1755.1999.00627.x
Peer Reviewed verified by ORBi

Cazzola, M., Beguin, Y., Bergamaschi, G., Guarnone, R., Cerani, P., Barella, S., Cao, A., & Galanello, R. (1999). Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. British Journal of Haematology, 106 (3), 752-5. doi:10.1046/j.1365-2141.1999.01600.x
Peer Reviewed verified by ORBi

Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9.
Peer Reviewed verified by ORBi

Beguin, Y. (1999). Erythropoietin and platelet production. Haematologica, 84 (6), 541-7.
Peer Reviewed verified by ORBi

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999). Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 94 (2), 429-33. doi:10.1182/blood.v94.2.429.414k26_429_433
Peer Reviewed verified by ORBi

Cornu, G., Vermylen, C., Ferster, A., Brichard, B., Ninane, J., Ferrant, A., Zenebergh, A., Maes, P., Dhooge, C., Benoit, Y., Beguin, Y., Dresse, M.-F., & Sariban, E. (1999). La greffe de cellules souches hematopoietiques dans la drepanocytose. Archives de Pédiatrie, 6 Suppl 2, 345s-347. doi:10.1016/s0929-693x(99)80463-1
Peer Reviewed verified by ORBi

Dresse, M.-F., Boogaerts, M., Vermylen, C., Noens, L., Ferrant, A., Schots, R., Doyen, C., Bron, D., Berneman, Z., Ferster, A., Benoit, Y., Demuynck, H., & Beguin, Y. (1999). The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor. Haematologica, 84 (7), 637-42.
Peer Reviewed verified by ORBi

Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x
Peer Reviewed verified by ORBi

Cazzola, M., Guarnone, R., Cerani, P., Centenara, E., Rovati, A., & Beguin, Y. (1998). Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood, 91 (6), 2139-45. doi:10.1182/blood.v91.6.2139.2139_2139_2145
Peer Reviewed verified by ORBi

Beguin, Y. (1998). Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer. Medical Oncology, 15 Suppl 1, 38-46.
Peer Reviewed verified by ORBi

Baudoux, E., Beguin, Y., Cornu, G., Brichard, B., Debruyn, C., De Bruyere, M., De Hemptinne, D., Delforge, A., Deneys, V., Fillet, G., Germeau, N., Joris, I., Lefevre, P., Massy, M., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Sondag, D., Van Cauwenberge, J.-R., ... Strijckmans, P. (1998). Circadian and seasonal variations of hematopoiesis in cord blood. Bone Marrow Transplantation, 22 Suppl 1, 12.
Peer Reviewed verified by ORBi

Baron, F., Hermanne, J.-P., Dowlati, A., Weber, T., Thiry, A., Fassotte, M.-F., Fillet, G., & Beguin, Y. (1998). Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21 (9), 951-4. doi:10.1038/sj.bmt.1701198
Peer Reviewed verified by ORBi

Baron, F., Sadzot, B., Wang, F.-C., & Beguin, Y. (1998). Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 22 (2), 197-200. doi:10.1038/sj.bmt.1701297
Peer Reviewed verified by ORBi

Pierard, G., Nikkels, N., Nikkels, A., Arrese Estrada, J., Pierard, C., Jerusalem, G., Beguin, Y., & Fillet, G. (1998). Epidermal Calprotectin Expression in Lymphocyte-Depleted Cutaneous Graft-versus-Host Reaction. Archivos Argentinos de Dermatologia, 48, 139-142.
Peer Reviewed verified by ORBi

Vermylen, C., Cornu, G., Ferster, A., Brichard, B., Ninane, J., Ferrant, A., Zenebergh, A., Maes, P., Dhooge, C., Benoit, Y., Beguin, Y., Dresse, M.-F., & Sariban, E. (1998). Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplantation, 22 (1), 1-6. doi:10.1038/sj.bmt.1701291
Peer Reviewed verified by ORBi

Baron, F., Hermanne, J. P., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1998). Le cas clinique du mois. Association d'une maladie de Hodgkin et d'un syndrome nephrotique. Revue Médicale de Liège, 53 (11), 651-3.
Peer reviewed

Beguin, Y. (1998). Prediction of response to optimize outcome of treatment with erythropoietin. Seminars in Oncology, 25 (3 Suppl 7), 27-34.
Peer Reviewed verified by ORBi

Beguin, Y., Baudoux, E., Sautois, B., Fraipont, V., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Sondag, D., & Fillet, G. (1998). Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion, 38 (2), 199-208. doi:10.1046/j.1537-2995.1998.38298193106.x
Peer Reviewed verified by ORBi

Beguin, Y., Baron, F., & Fillet, G. (1998). Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. Haematologica, 83 (12), 1076-81.
Peer Reviewed verified by ORBi

Corazza, F., Beguin, Y., Bergmann, P., Andre, M.-E., Ferster, A., Devalck, C., Fondu, P., Buyse, M., & Sariban, E. (1998). Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood, 92 (5), 1793-8. doi:10.1182/blood.v92.5.1793.417k23_1793_1798
Peer Reviewed verified by ORBi

Hellstrom-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I. M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Nilsson-Ehle, H., Samuelsson, J., Tangen, J. M., Winqvist, I., Oberg, G., Osterborg, A., & Ost, A. (1998). Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood, 92 (1), 68-75. doi:10.1182/blood.v92.1.68.413k23_68_75
Peer Reviewed verified by ORBi

van Iperen, C. E., Kraaijenhagen, R. J., Biesma, D. H., Beguin, Y., Marx, J. J., & van de Wiel, A. (1998). Iron metabolism and erythropoiesis after surgery. British Journal of Surgery, 85 (1), 41-5. doi:10.1046/j.1365-2168.1998.00571.x
Peer Reviewed verified by ORBi

Beguin, Y. (1998). A risk-benefit assessment of epoetin in the management of anaemia associated with cancer. Drug Safety: An International Journal of Medical Toxicology and Drug Experience, 19 (4), 269-82. doi:10.2165/00002018-199819040-00003
Peer Reviewed verified by ORBi

Dowlati, A., Loo, Bury, T., Fillet, G., & Beguin, Y. (1997). Soluble and cell-associated transferrin receptor in lung cancer. British Journal of Cancer, 75 (12), 1802-6. doi:10.1038/bjc.1997.307
Peer Reviewed verified by ORBi

Sautois, B., Fillet, G., & Beguin, Y. (1997). Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Experimental Hematology, 25 (2), 103-8.
Peer reviewed

Baron, F., & Beguin, Y. (1997). Complications hepatiques de la chimiotherapie. De la cytolyse banale a la maladie veino-occlusive du foie. Revue Médicale de Liège, 52 (2), 93-7.
Peer reviewed

Baron, F., & Beguin, Y. (1997). Complications hépatiques de la chimiothérapie : de la cytolyse banale à la maladie veino-occlusive du foie. Médecine and Chirurgie Digestives, 26, 269-272.
Peer Reviewed verified by ORBi

Beguin, Y. (1997). Mechanisms of cancer-related anemia and rationale for erythropoietin treatment. Cancer Biotherapy, 1, 88-96.
Peer Reviewed verified by ORBi

Baron, F., Deprez, M., & Beguin, Y. (1997). The veno-occlusive disease of the liver. Haematologica, 82 (6), 718-25.
Peer Reviewed verified by ORBi

Beguin, Y., Sautois, B., Forget, P., Bury, J., & Fillet, G. (1997). Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen. Cancer, 79 (7), 1351-4. doi:10.1002/(SICI)1097-0142(19970401)79:7<1351::AID-CNCR12>3.0.CO;2-Z
Peer Reviewed verified by ORBi

Beguin, Y., Grek, V., Weber, G., Sautois, B., Paquot, N., Pereira-Martins, M., Scheen, A., Lefèbvre, P., & Fillet, G. (1997). Acute Functional Iron Deficiency in Obese Subjects During a Very-Low-Energy All-Protein Diet. American Journal of Clinical Nutrition, 66 (1), 75-9. doi:10.1093/ajcn/66.1.75
Peer Reviewed verified by ORBi

Cazzola, M., Borgna-Pignatti, C., Locatelli, F., Ponchio, L., Beguin, Y., & De Stefano, P. (1997). A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion, 37 (2), 135-40. doi:10.1046/j.1537-2995.1997.37297203514.x
Peer Reviewed verified by ORBi

Dowlati, A., R'Zik, S., Fillet, G., & Beguin, Y. (1997). Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production. British Journal of Haematology, 97 (2), 297-9. doi:10.1046/j.1365-2141.1997.472694.x
Peer Reviewed verified by ORBi

Cavill, I., Macdougall, I. C., Gokal, R., Beguin, Y., Peters, T. J., Pippard, M., Schaefer, R. M., & Winearls, C. G. (1997). Iron management in patients on rHuEpo. British Journal of Renal Medicine, 2, 6-8.
Peer reviewed

Beguin, Y., Lampertz, S., Bron, D., & Fillet, G. (1996). Serum erythropoietin in chronic lymphocytic leukaemia. British Journal of Haematology, 93 (1), 154-6. doi:10.1046/j.1365-2141.1996.452992.x
Peer Reviewed verified by ORBi

Hermanne, J.-P., TASSIN, F., Beguin, Y., & Fillet, G. (1996). Actualités thérapeutiques dans la thrombocytémie essentielle. Médecine et Hygiène, 54, 1487-1489.
Peer Reviewed verified by ORBi

Beguin, Y. (1996). La greffe de cellules souches hematopoietiques (greffe de moelle osseuse"): indications, modalites et risques.". Revue Médicale de Liège, 51 (4), 270-5.
Peer reviewed

Pasquasy, V., Delvenne, P., Thiry, A., Beguin, Y., & Boniver, J. (1996). Confrontation anatomo-clinique. Purpura thrombocytopenique thrombotique dans le decours d'une greffe de moelle. Revue Médicale de Liège, 51 (11), 714-7.
Peer reviewed

Beguin, Y. (1996). Erythropoietin and the anemia of cancer. Acta Clinica Belgica, 51 (1), 36-52. doi:10.1080/17843286.1996.11718483
Peer Reviewed verified by ORBi

Cazzola, M., Ponchio, L., de Benedetti, F., Ravelli, A., Rosti, V., Beguin, Y., Invernizzi, R., Barosi, G., & Martini, A. (1996). Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood, 87 (11), 4824-30. doi:10.1182/blood.v87.11.4824.bloodjournal87114824
Peer Reviewed verified by ORBi

Cazzola, M., Ponchio, L., Pedrotti, C., Farina, G., Cerani, P., Lucotti, C., Novella, A., Rovati, A., Bergamaschi, G., & Beguin, Y. (1996). Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy. Haematologica, 81 (5), 434-41.
Peer Reviewed verified by ORBi

Beguin, Y., Collignon, J., Laurent, C., & Fillet, G. (1996). Spontaneous complete remission and recovery of donor haemopoiesis without GVHD after relapse and apparent marrow graft rejection in poor-prognosis myelodysplastic syndrome. British Journal of Haematology, 94 (3), 507-9. doi:10.1046/j.1365-2141.1996.d01-1824.x
Peer Reviewed verified by ORBi

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1995). Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin. British Journal of Haematology, 89 (1), 17-23. doi:10.1111/j.1365-2141.1995.tb08916.x
Peer Reviewed verified by ORBi

Cazzola, M., De Stefano, P., Ponchio, L., Locatelli, F., Beguin, Y., Dessi, C., Barella, S., Cao, A., & Galanello, R. (1995). Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. British Journal of Haematology, 89 (3), 473-8. doi:10.1111/j.1365-2141.1995.tb08351.x
Peer Reviewed verified by ORBi

Biesma, D. H., Van de Wiel, A., Beguin, Y., Kraaijenhagen, R. J., & Marx, J. J. (1995). Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. European Journal of Clinical Investigation, 25 (6), 383-9. doi:10.1111/j.1365-2362.1995.tb01718.x
Peer Reviewed verified by ORBi

Beguin, Y. (1995). Pharma clinics. Comment je traite ... une anemie (3e partie). Revue Médicale de Liège, 50 (12), 497-8.
Peer reviewed

Beguin, Y. (1995). Erythropoiesis and erythropoietin in multiple myeloma. Leukemia and Lymphoma, 18 (5-6), 413-21. doi:10.3109/10428199509059639
Peer Reviewed verified by ORBi

Dowlati, A., Honore, P., Damas, P., Deprez, M., Delwaide, J., Fillet, G., & Beguin, Y. (1995). Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation. Transplantation, 60 (1), 106-9. doi:10.1097/00007890-199507150-00020
Peer Reviewed verified by ORBi

Davies, S. V., Fegan, C. D., Kendall, R., Beguin, Y., & Cavill, I. (1995). Serum erythropoietin during autologous bone marrow transplantation: relationship to measures of erythroid activity. Clinical and Laboratory Haematology, 17 (2), 139-44.
Peer Reviewed verified by ORBi

Danielson, B., Beguin, Y., Bommer, J., Cannata, B., De Broe, M.-E., Drüeke, T. B., Ittel, T. H., Jolliffe, L. K., Krantz, S. B., Nielsen, O. J., Pippard, M. J., Rosenlöf, K., Stockenhuber, B., & Winearls, C. G. (1995). R-HuEPO hyporesponsiveness - who and why ? Nephrology Dialysis Transplantation, 10, 69-76. doi:10.1093/ndt/10.supp2.69
Peer Reviewed verified by ORBi

Beguin, Y. (1995). Comment j'explore ... une anemie (2eme partie). Revue Médicale de Liège, 50 (11), 487-8.
Peer reviewed

Beguin, Y. (1995). Biology and clinical uses of erythropoietin in infants and children. International Journal of Pediatric Hematology/Oncology, 2, 457-470.
Peer Reviewed verified by ORBi

Beguin, Y. (1995). Comment j'explore... Une anemie (1e partie). Revue Médicale de Liège, 50 (10), 443-4.
Peer reviewed

Locatelli, F., Zecca, M., Pedrazzoli, P., Prete, L., Quaglini, S., Comoli, P., De Stefano, P., Beguin, Y., Robustelli della Cuna, G., Severi, F., & Cazzola, M. (1994). Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. Bone Marrow Transplantation, 13 (4), 403-10.
Peer Reviewed verified by ORBi

Bowen, D. T., Culligan, D., Beguin, Y., Kendall, R., & Willis, N. (1994). Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters. Leukemia, 8 (1), 151-5.
Peer Reviewed verified by ORBi

Fraipont, V., Beguin, Y., & Fillet, G. (1994). L'anemie ferriprive de la grossesse. Revue Médicale de Liège, 49 (8), 436-45.
Peer reviewed

Locatelli, F., Zecca, M., Ponchio, L., Beguin, Y., Giorgiani, G., Maccario, R., Bonetti, F., De Stefano, P., & Cazzola, M. (1994). Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation. Bone Marrow Transplantation, 14 (6), 929-35.
Peer Reviewed verified by ORBi

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1994). Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters. European Journal of Haematology, 53 (5), 265-70. doi:10.1111/j.1600-0609.1994.tb01318.x
Peer Reviewed verified by ORBi

Biesma, D. H., Van de Wiel, A., Beguin, Y., Kraaijenhagen, R. J., & Marx, J. J. (1994). Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. European Journal of Clinical Investigation, 24 (6), 426-32. doi:10.1111/j.1365-2362.1994.tb02187.x
Peer Reviewed verified by ORBi

Martelli, M., Ponchio, L., Beguin, Y., Meloni, G., Mandelli, F., & Cazzola, M. (1994). Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin. Haematologica, 79 (5), 456-9.
Peer Reviewed verified by ORBi

Locatelli, F., Zecca, M., Beguin, Y., Giorgiani, G., Ponchio, L., De Stefano, P., & Cazzola, M. (1993). Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation. British Journal of Haematology, 84 (4), 752-4. doi:10.1111/j.1365-2141.1993.tb03158.x
Peer Reviewed verified by ORBi

Beguin, Y., Oris, R., & Fillet, G. (1993). Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. Bone Marrow Transplantation, 11 (4), 285-92.
Peer Reviewed verified by ORBi

Beguin, Y., Clemons, G. K., Pootrakul, P., & Fillet, G. (1993). Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood, 81 (4), 1067-76. doi:10.1182/blood.v81.4.1067.1067
Peer Reviewed verified by ORBi

Beguin, Y. (1993). Mesures quantitatives de l'erythropoiese. Le recepteur soluble de la transferrine. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 148 (1-2), 100-4; discussion 105-7.
Peer Reviewed verified by ORBi

Feron, C., Gothot, A., Grosdent, J.-C., Van Cauwenberge, J.-R., Schaaps, J.-P., Beguin, Y., & Paulus, J.-M. (1993). Purification, expansion, and multiple fluorochrome labeling of cord blood hemopoietic precursors: preliminary results. Journal of Hematotherapy, 2 (2), 259-61. doi:10.1089/scd.1.1993.2.259
Peer Reviewed verified by ORBi

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1993). Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood, 82 (7), 2010-6. doi:10.1182/blood.v82.7.2010.bloodjournal8272010
Peer Reviewed verified by ORBi

Beguin, Y., Lampertz, S., De Groote, D., Igot, D., Malaise, M., & Fillet, G. (1993). Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia, 7 (12), 2019-2025.
Peer Reviewed verified by ORBi

Elira-Dokekias, A., R'Zik, S., Beguin, Y., & Fillet, G. (1992). Monitoring of erythropoiesis by serum transferrin receptor levels in a case of chronic lymphocytic leukaemia and pure red cell aplasia treated with ciclosporin. Nouvelle Revue Française d'Hématologie, 34 (3), 257-8.
Peer Reviewed verified by ORBi

Ponchio, L., Beguin, Y., Farina, G., Pedrazzoli, P., Pedrotti, C., Poggi, G., Rosti, V., Bergamaschi, G., Battistel, V., & Cazzola, M. (1992). Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia. Haematologica, 77 (6), 494-501.
Peer Reviewed verified by ORBi

De Groote, D., Zangerlé, P.-F., Gevaert, Y., Fassotte, M.-F., Beguin, Y., Noizat-Pirenne, F., Pirenne, J., Gathy, R., Lopez Y Cadenas, M., & Dehart, I. (1992). Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine, 4 (3), 239-48. doi:10.1016/1043-4666(92)90062-V
Peer Reviewed verified by ORBi

Beguin, Y., Yerna, M., Loo, M., Weber, M., & Fillet, G. (1992). Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. British Journal of Haematology, 82 (4), 648-53. doi:10.1111/j.1365-2141.1992.tb06939.x
Peer Reviewed verified by ORBi

Cazzola, M., & Beguin, Y. (1992). Serum erythropoietin levels during haematinic treatment. British Journal of Haematology, 82, 631-632.
Peer Reviewed verified by ORBi

Antoine, N., Beckers, C., Marcoty, C., Bosseloir, A., Beguin, Y., Schaaf-Lafontaine, N., & Simar, L. J. (1992). Expression de l'antigene DRC1 par les cellules leucemiques. Revue Médicale de Liège, 47 (2), 95-9.
Peer reviewed

Beguin, Y. (1992). The soluble transferrin receptor: biological aspects and clinical usefulness as quantitative measure of erythropoiesis. Haematologica, 77 (1), 1-10.
Peer Reviewed verified by ORBi

Cazzola, M., Ponchio, L., Beguin, Y., Rosti, V., Bergamaschi, G., Liberato, N. L., Fregoni, V., Nalli, G., Barosi, G., & Ascari, E. (1992). Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood, 79 (1), 29-37. doi:10.1182/blood.v79.1.29.bloodjournal79129
Peer Reviewed verified by ORBi

Cazzola, M., & Beguin, Y. (1992). New tools for clinical evaluation of erythron function in man. British Journal of Haematology, 80 (3), 278-84. doi:10.1111/j.1365-2141.1992.tb08133.x
Peer Reviewed verified by ORBi

Beguin, Y., Sautois, B., & Fillet, G. (1991). Perspectives diagnostiques et thérapeutiques de l'érythropoïétine. Médecine et Hygiène, 49, 2034-2045.
Peer Reviewed verified by ORBi

Beguin, Y., Clemons, G. K., Oris, R., & Fillet, G. (1991). Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Blood, 77 (4), 868-73. doi:10.1182/blood.v77.4.868.bloodjournal774868
Peer Reviewed verified by ORBi

Beguin, Y., Loo, M., & Fillet, G. (1991). Le dosage du récepteur circulant de la transferringe : une nouveauté pour quantifier l'érythropoïèse. Médecine et Hygiène, 49, 2041-2045.
Peer Reviewed verified by ORBi

Beguin, Y., Lipscei, G., Thoumsin, H., & Fillet, G. (1991). Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood, 78 (1), 89-93. doi:10.1182/blood.v78.1.89.89
Peer Reviewed verified by ORBi

Beguin, Y., Lipscei, G., Oris, R., Thoumsin, H., & Fillet, G. (1990). Serum immunoreactive erythropoietin during pregnancy and in the early postpartum. British Journal of Haematology, 76 (4), 545-9. doi:10.1111/j.1365-2141.1990.tb07914.x
Peer Reviewed verified by ORBi

Beguin, Y., & Fillet, G. (1990). Erythropoietine: utilisation diagnostique et therapeutique. Revue Médicale de Liège, 45 (6), 261-7.
Peer reviewed

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., Fillet, G., & Weber, G. (1990). Use of PIXE to measure serum copper, zinc, selenium, and bromine in patients with hematologic malignancies. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B49, 202-204. doi:10.1016/0168-583X(90)90243-N
Peer Reviewed verified by ORBi

Andrien, F., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1990). Traitement des lymphomes non hodgkiniens : de l'abstention thérapeutique à la greffe de moelle. Médecine et Hygiène, 48, 3672-3676.
Peer Reviewed verified by ORBi

Fassotte, M.-F., Beguin, Y., Andrien, F., & Fillet, G. (1990). Allogreffes et autogreffes de moelle osseuse. Indications, résultats, perspectives. Médecine et Hygiène, 48, 3666-3671.
Peer Reviewed verified by ORBi

Beguin, Y., Fassotte, M.-F., Hay, F., Dokekias, A., Andrien, F., Bours, V., Moutschen, M., Runde, V., Bury, J., & Fillet, G. (1990). Greffes de moelle osseuse: bilan au CHU de Liege. Revue Médicale de Liège, 45 (6), 268-79.
Peer reviewed

Huebers, H. A., Beguin, Y., Pootrakul, P., Einspahr, D., & Finch, C. A. (1990). Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood, 75 (1), 102-7. doi:10.1182/blood.v75.1.102.102
Peer Reviewed verified by ORBi

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., & Fillet, G. (1990). Relationship of serum selenium to tumor activity in acute non lymphocytic leukemia (ANLL) and chronic lymohocytic leukemia (CLL). Metal ions in Biology and Medecine, 500-502.
Peer reviewed

Beguin, Y., Bours, V., Delbrouck, J. M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (November 1989). Relationship of Serum Selenium Levels to Tumor Activity in Acute Non-Lymphocytic Leukemia. Carcinogenesis, 10 (11), 2089-91. doi:10.1093/carcin/10.11.2089
Peer Reviewed verified by ORBi

Beguin, Y., Huebers, H. A., Weber, G., Englebert, M., & Finch, C. A. (1989). Hepatocyte iron release in rats. Journal of Laboratory and Clinical Medicine, 113 (3), 346-54.
Peer Reviewed verified by ORBi

Fillet, G., Baldelli, L., & BEGUIN, Y. (1989). Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood, 74 (2), 844-51. doi:10.1182/blood.v74.2.844.bloodjournal742844
Peer Reviewed verified by ORBi

Beguin, Y., Fillet, G., Bury, J., & Fairon, Y. (1989). Ferrokinetic study of splenic erythropoiesis: relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesis. American Journal of Hematology, 32 (2), 123-8. doi:10.1002/ajh.2830320209
Peer Reviewed verified by ORBi

Defraigne, J.-O., Closon, M.-T., Bruyninx, L., Dewandre, J., Hourlay, P., Meurisse, M., Honore, P., Bury, J., & Beguin, Y. (1989). Experience with a totally implantable catheter in adult patients: a single institution retrospective study of 114 cases. European Journal of Surgical Oncology, 15 (1), 61-4.
Peer Reviewed verified by ORBi

Grek, V., Hay, F., Beguin, Y., Andrien, F., Dokekias, A., & Fillet, G. (1989). La leucémie a tricholeucocyte: 30 ans après. Revue Médicale de Liège, 44 (10), 358-64.
Peer reviewed

Fillet, G., & Beguin, Y. (1989). Reutilisation du fer dans l'organisme et regulation du fer de reserve. Interet du dosage du recepteur de la transferrine dans le plasma. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 144 (1-2), 113-8; discussion 118-20.
Peer Reviewed verified by ORBi

Beguin, Y., Huebers, H., & Finch, C. A. (1988). Random distribution of iron among the two binding sites of transferrin in patients with various hematologic disorders. Clinica Chimica Acta, 173 (3), 299-304. doi:10.1016/0009-8981(88)90017-4
Peer Reviewed verified by ORBi

Beguin, Y., Bergamaschi, G., Huebers, H. A., & Finch, C. A. (1988). The behavior of asialotransferrin-iron in the rat. American Journal of Hematology, 29 (4), 204-10. doi:10.1002/ajh.2830290406
Peer Reviewed verified by ORBi

Beguin, Y., & Fillet, G. (1988). Les états de surcharge en fer: hémosiderose et hémochromatose. Revue Médicale de Liège, 43 (8), 275-82.
Peer reviewed

Beguin, Y., Huebers, H. A., Josephson, B., & Finch, C. A. (1988). Transferrin receptors in rat plasma. Proceedings of the National Academy of Sciences of the United States of America, 85 (2), 637-40. doi:10.1073/pnas.85.2.637
Peer Reviewed verified by ORBi

Beguin, Y., Stray, S. M., Cazzola, M., Huebers, H. A., & Finch, C. A. (1988). Ferrokinetic measurement of erythropoiesis. Acta Haematologica, 79 (3), 121-6. doi:10.1159/000205743
Peer Reviewed verified by ORBi

Fillet, G., Bury, J., Beguin, Y., Duvivier, A., Hoyoux, C., & Bours, V. (1987). Les cancers hématologiques en 1987. Chimiothérapie et immunothérapie. Revue Médicale de Liège, 42 (10), 496-502.
Peer reviewed

Bury, J., Andrien, F., Baudrihaye, M., Beguin, Y., Duvivier, A., Hoyoux, C., Runde, V., & Fillet, G. (1987). Greffe de moelle: résultats préliminaires au CHU. Revue Médicale de Liège, 42 (10), 510-5.
Peer reviewed

Beguin, Y., Bury, J., Delbrouck, J. M., Fillet, G., Robaye, G., Roelandts, I., & Weber, G. (1987). Serum zinc and copper as prognostic factors in acute nonlymphocytic leukemia. Haematology and Blood Transfusion, 30, 380-4. doi:10.1007/978-3-642-71213-5_64
Peer Reviewed verified by ORBi

Beguin, Y., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (1987). Correlation of serum trace elements with other biological parameters in hemoproliferative disorders. Trace element analytical chemistry in medicine and biology, 4, 537-545.
Peer reviewed

Beguin, Y., Brasseur, F., Weber, G., Bury, J., Delbrouck, J.-M., Roelandts, I., Robaye, G., & Fillet, G. (1987). Observations of serum trace elements in chronic lymphocytic leukemia. Cancer, 60 (8), 1842-6. doi:10.1002/1097-0142(19871015)60:8<1842::AID-CNCR2820600828>3.0.CO;2-W
Peer Reviewed verified by ORBi

Beguin, Y., Boniver, J., Bury, J., Defraigne, J.-O., Detroz, B., Fillet, G., & Lejeune, G. (1987). Plasmacytoma of the thyroid: a case report, a study with use of the immunoperoxidase technique, and a review of the literature. Surgery, 101 (4), 496-500.
Peer Reviewed verified by ORBi

Beguin, Y., Weber, G., Delbrouck, J. M., Roelandts, I., Robaye, G., Bury, J., & Fillet, G. (1986). Serum trace elements during chemotherapy for acute myelogenous leukemia. Acta Pharmacologica et Toxicologica, 59 Suppl 7, 270-3. doi:10.1111/j.1600-0773.1986.tb02760.x
Peer Reviewed verified by ORBi

Andrien, F., Lemaire, M., Beguin, Y., Bury, J., Closon, J., David, J.-L., Dejardin-Closon, M.-T., Duvivier, A., Fillet, G., & Tjean, M. (1986). Second tumors and myeloproliferative diseases after Hodgkin's disease treatment. Leukemia Research, 10, 887.
Peer Reviewed verified by ORBi

Beguin, Y., Bury, J., Fillet, G., & Lennes. (1985). Treatment of acute nonlymphocytic leukemia in young and elderly patients. Cancer, 56 (11), 2587-92. doi:10.1002/1097-0142(19851201)56:11<2587::AID-CNCR2820561109>3.0.CO;2-8
Peer Reviewed verified by ORBi

Weber, G., Robaye, G., BARTSCH, P., Collignon, A., Beguin, Y., Roelandts, I., & Delbrouck, J.-M. (1984). Trace element analysis by PIXE in several biomedical fields. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B3, 326-331. doi:10.1016/0168-583X(84)90388-4
Peer Reviewed verified by ORBi

Articles accepted in journal without reviewing

Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique.

Baron, F., & Beguin, Y. (2010). GVHD chronique et effet anti-tumoral. Correspondance en Onco-Hématologie, 5, 12-16.

Dresse, M.-F., & Beguin, Y. (2007). Haematopoietic stem cell transplantation for children in Belgium. Tijdschrift van de Belgische Kinderarts, 1, 44-51.

Hermanne, J.-P., & Beguin, Y. (1997). Use of recombinant human erythropoietin after allogeneic bone marrow transplantation. Erythropoiesis, 8, 80-83.

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., & Fillet, G. (1994). Significance of soluble transferrin receptor. Molecular Biology of Hematopoiesis, 451-464.

Beguin, Y. (1994). Greffes de moelle dans les hémoglobinopathies. Mini Acta, 26, 249-250.

Beguin, Y. (1993). Contribution of the soluble transferrin receptor to the quantitative evaluation of erythroid marrow function. Erythropoiesis, 4, 99-109.

Beguin, Y., & Fillet, G. (1991). Erythropoïétine : utilisation diagnostique et thérapeutique. Revue de l'Association Belge des Technologues de Laboratoire, 18 (3), 161-168.

Articles accepted in conference proceedings

VANDERMEULEN, M., Mohamed Wais, M., DELBOUILLE, M.-H., MAGGIPINTO, G., BEGUIN, Y., & DETRY, O. (August 2021). Long term follow-up of liver transplant recipients after allogeneic mesenchymal stromal cell infusion. Transplant International, 34 (S1 OP282), 45.
Peer Reviewed verified by ORBi

Ritacco, C., Ehx, G., Canti, L., DUBOIS, S., Vandenhove, B., SERVAIS, S., Beguin, Y., & Baron, F. (01 March 2020). Ptcy Prevents Xenogeneic Gvhd without Abrogating Gvl Effects. Biology of Blood and Marrow Transplantation, 26 (3), 168. doi:10.1016/j.bbmt.2019.12.028
Peer Reviewed verified by ORBi

VANDERMEULEN, M., MAGGIPINTO, G., JOURET, F., BEGUIN, Y., & DETRY, O. (September 2017). DO MESENCHYMAL STROMAL CELLS PROMOTE HLA SPECIFIC ANTIBODIES FORMATION AFTER INFUSION IN LIVER TRANSPLANT RECIPIENTS? Transplant International, 30 (S2), 548 (PLB051.
Peer Reviewed verified by ORBi

Ehx, G., Hannon, M., DUBOIS, S., Daulne, C., Drion, P., BEGUIN, Y., Humblet-Baron, S., & BARON, F. (March 2017). Immunomodulatory effects of rapamycin in xenogeneic Graft versus Host Disease. Biology of Blood and Marrow Transplantation, 23 (3), 365–S366. doi:10.1016/j.bbmt.2016.12.314
Peer Reviewed verified by ORBi

Ehx, G., HANNON, M., Dubois, S., Daulne, C., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (10 February 2017). Immunomodulatory effects of rapamycin in xenogeneic Graft versus Host Disease. Journal of Clinical Immunology, 37 (2), 197-266. doi:10.1007/s10875-017-0372-z
Peer Reviewed verified by ORBi

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & BEGUIN, Y. (January 2017). UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE. Transplant International, 30 (suppl 1), 8 (O12.
Peer Reviewed verified by ORBi

Farhat, K., Bodart, G., Martens, H., Baron, F., Beguin, Y., Moutschen, M., Salvatori, R., & Geenen, V. (2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH). Neuroimmunomodulation.
Peer Reviewed verified by ORBi

HAUZEUR, J.-P., Tungouz, M., LECHANTEUR, C., Beguin, Y., BAUDOUX, E., de maertelaer, V., Pather, S., Katz, R., Ino, J., Egrise, D., Malaise, M., & Gangji, V. (October 2016). Ostéoblastes autologues (PREOB®) versus concentré de moelle autologue dans l’ostéonécrose de la tête fémorale : étude randomisée. Revue de Chirurgie Orthopédique et Traumatologie, 102, 73. doi:10.1016/j.rcot.2016.08.002
Peer reviewed

Ehx, G., Fransolet, G., de Leval, L., D'Hondt, S., Lucas, S., Hannon, M., Delens, L., DUBOIS, S., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (March 2016). Azacytidine Enhances Regulatory T-Cells In Vivo and Prevents Experimental Xenogeneic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation, 22 (3), 393. doi:10.1016/j.bbmt.2015.11.917
Peer Reviewed verified by ORBi

Heusschen, R., Muller, J., Binsfeld, M., Marty, C., Plougonven, E., DUBOIS, S., Mahli, N., Moermans, K., Carmeliet, G., Léonard, A., BARON, F., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2016). SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6.
Peer Reviewed verified by ORBi

Sid, S., LUTTERI, L., BEGUIN, Y., Louis, E., Beckers, A., & VALDES SOCIN, H. G. (2015). Familial thyrogastric autoimmune syndrome : a study of 22 kindreds. In Abstract book - 20th Annual Congress of the Belgian Society of Internal Medicine.

WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278.
Peer Reviewed verified by ORBi

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., HONORE, P., & BEGUIN, Y. (November 2015). Infusion of third-party mesenchymal stem cells after liver transplantation: a phase-1, open-label, clinical study. Transplant International, 28 (S4), 10/O27.
Peer Reviewed verified by ORBi

WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3).
Peer Reviewed verified by ORBi

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (April 2015). Infusion of third-party mesenchymal stromal cells after liver transplantation: a phase 1, open-label, clinical study. Journal of Hepatology, 62 (S2), 311 (P0052.
Peer Reviewed verified by ORBi

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (March 2015). Infusion of third-party mesenchymal stream cells after liver transplantation: a phase-1, open-label, clinical study. Acta Gastro-Enterologica Belgica, 78 (1), 29.
Peer Reviewed verified by ORBi

Heusschen, R., Muller, J., Binsfeld, M., Plougonven, E., Mahli, N., Carmeliet, G., Léonard, A., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2015). The SRC inhibitor AZD0530 prevents the development of osteolytic bone disease in multiple myeloma. Blood.
Peer Reviewed verified by ORBi

Heusschen, R., Muller, J., Binsfeld, M., Plougonven, E., Mahli, N., Carmeliet, G., Léonard, A., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2015). The SRC inhibitor AZD0530 prevents the development of osteolytic bone disease in multiple myeloma. Blood, 126 (23), 3018.
Peer Reviewed verified by ORBi

Muller, J., Binsfeld, M., DUBOIS, S., Carmeliet, G., Beguin, Y., Heusschen, R., & CAERS, J. (2015). The anti-angiogenic peptide Anginex blocks osteoclastogenesis. Belgian Journal of Hematology, Abstracts book.
Peer Reviewed verified by ORBi

FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

BEGUIN, Y., ZACHEE, P., MAERTENS, J., KERRE, T., ORY, A., SEIDEL, L., GRAUX, C., LEWALLE, P., VAN GELDER, M., THEUNISSEN, K., WILLEMS, E., EMONDS, M.-P., DE BECKER, A., & BARON, F. (December 2014). Nonmyeloablative allogeneic hematopoietic cell transplantation following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. Blood, 124 (21), 542.
Peer Reviewed verified by ORBi

JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948.
Peer Reviewed verified by ORBi

VALDES SOCIN, H. G., Potorac, I., DE PASQUAL, A., BARON, F., DE PRIJCK, B., Beguin, Y., & Beckers, A. (2014). Leucémie myéloblastique aiguë : sécrétion paranéoplasique de GH et de PRL ? In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Françaose d'Endocrinologie, Lyon 5-8 novembre 2014.

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (2014). Long-term survival in patients receiving rhEPO following allogeneic hematopoietic cell transplantation. Belgian Journal of Hematology, 14.
Peer Reviewed verified by ORBi

SID, S., Dugauquier, D., DE PRIJCK, B., Bonnet, C., & Beguin, Y. (2014). Hemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 17-18.
Peer Reviewed verified by ORBi

Heusschen, R., Schulkens, I., Muller, J., Griffoen, A., Beguin, Y., Thijssen, V., & CAERS, J. (2014). Galectins in cancer: jacks of all trades. International Journal of Molecular Medicine.
Peer Reviewed verified by ORBi

Binsfeld, M., BEGUIN, Y., Belle, L., Otjacques, E., HANNON, M., BRIQUET, A., Drion, P., Bogen, B., Baron, F., & CAERS, J. (2014). Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation. Belgian Journal of Hematology.

Muller, J., CAERS, J., Binsfeld, M., Dubois, S., Carmeliet, G., BEGUIN, Y., & Heusschen, R. (2014). Galectin expression in the multiple myeloma microenvironment. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

Binsfeld, M., Heusschen, R., Lamour, V., Van Valckenborgh, E., Bellahcene, A., Baron, F., BEGUIN, Y., & CAERS, J. (2014). Multiple myeloma cells instruct myeloid-derived suppressor cells to release pro-angiogenic cytokines. Belgian Journal of Hematology.

Belle, L., Ehx, G., SOMJA, J., BINSFELD, M., Hannon, M., Caers, J., Fransolet, G., Beguin, Y., Humblet-Baron, S., & Baron, F. (December 2013). Combination Of Regulatory T Cells and Rapamycin As Treatment For Experimental Chronic Graft-Versus-Host Disease. Blood, 122 (21), 4474.
Peer Reviewed verified by ORBi

Belle, L., BINSFELD, M., DUBOIS, S., Hannon, M., Caers, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & Baron, F. (February 2013). Prevention of murine sclerodermatous chronic graft-versus-host disease by Rapamycin. Biology of Blood and Marrow Transplantation, 19, 317.
Peer Reviewed verified by ORBi

Belle, L., Binsfeld, M., HANNON, M., CAERS, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & Baron, F. (2013). Combination of Regulatory T Cells Injection with Rapamycin for Treatment of Chronic Graft-versus-Host Disease. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2013). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomised trial. Belgian Journal of Hematology, 16.
Peer Reviewed verified by ORBi

Hannon, M., LECHANTEUR, C., Somja, J., Lucas, S., Belle, L., Bruck, F., Baudoux, E., Beguin, Y., Humblet-Baron, S., & Baron, F. (2013). Infusion of CliniMACS (Myltenyi Biotec) Enriched Regulatory T Cells Delays Experimental Xenogeneic Graft-versus-Host Disease. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 15.

Binsfeld, M., Otjacques, E., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & CAERS, J. (2013). The Immunomodulating Peptide Thymosin Alpha 1 Has no Effect on Multiple Myeloma Evolution and on Immune Reconstitution. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 41.

Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Theunissen, K., Daulne, C., Willems, E., Belle, L., Binsfeld, M., Gothot, A., Beguin, Y., & Baron, F. (2013). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 38.

Belle, L., BINSFELD, M., Dubois, S., Hannon, M., CAERS, J., BRIQUET, A., MENTEN, C., Beguin, Y., Humbelt-Baron, S., & BARON, F. (April 2012). Rapamycin prevents experimental sclerodermatous chronic graft-versus-host disease in mice. Bone Marrow Transplantation, 47 Suppl 1.
Peer Reviewed verified by ORBi

SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (February 2012). Longitudinal Monitoring of Immune Reconstitution after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): Impact of T-Cell Depletion of the Graft. Biology of Blood and Marrow Transplantation, 18 (2), 274-S275. doi:10.1016/j.bbmt.2011.12.193
Peer Reviewed verified by ORBi

MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). Evidence for Expansion of Host-derived CMV-specific CD8+ T cells after Allogeneic Transplantation with Non-Myeloablative Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 27th General Meeting of the Belgian Hematological Society), 16.

MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). What is the Contribution of Host-Derived CMV Immunity after Allogeneic Transplantation following Non-Myeloablative Conditioning? Haematologica, 97 (Supplement 1), 720.
Peer Reviewed verified by ORBi

Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Theunissen, K., Daulne, C., Willems, E., Belle, L., Binsfeld, M., Gothot, A., Beguin, Y., & Baron, F. (2012). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Haematologica, 97 (Supplement 1), 180.
Peer Reviewed verified by ORBi

Binsfeld, M., Belle, L., Hannon, M., Hofgaard, Dubois, S., Otjacques, E., BEGUIN, Y., Bogen, BARON, F., & CAERS, J. (2012). Adaptation of a murine chronic GvH model to study graftversus- myeloma effect after allogeneic transplantation. Bone Marrow Transplantation, 47 (Suppl.1).
Peer Reviewed verified by ORBi

Belle, L., Bruck, F., FOGUENNE, J., Gothot, A., Beguin, Y., Baron, F., & BRIQUET, A. (2012). Imatinib and Nilotinib do not prevent adhesion and migration of human CD34+ in vitro and in immunodeficient mice. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

Binsfeld, M., Belle, L., Hannon, M., DUBOIS, S., Otjacques, E., Beguin, Y., Baron, F., & CAERS, J. (2012). Adaptation of a Murine Chronic GVH Model to Study Graft versus Myeloma Effect after Allogeneic Transplantation. Belgian Journal of Hematology, Abstracts book (Supplement of 27th General Meeting of the Belgian Hematological Society), 16.

Noterdaeme, T., Longree, L., Bataille, C., DE ROOVER, A., LAMPROYE, A., DELWAIDE, J., Beguin, Y., Honoré, P., & DETRY, O. (February 2011). LIVER TRANSPLANTATION FOR ACUTE HEPATIC FAILURE DUE TO CHEMOTHERAPY-INDUCED HEPATITIS B VIRUS REACTIVATION IN LYMPHOMA PATIENTS. Transplant International, 24 (1), 10-10.
Peer Reviewed verified by ORBi

BERNARD, C., HAUZEUR, J.-P., LECHANTEUR, C., VAN CAUWENBERGE, H., BEGUIN, Y., MALAISE, M., KURTH, W., GILLET, P., & HUSTINX, R. (2011). Evaluation of the homing process in the treatment of atrophic nonunion fractures by percutaneous autologous osteoblast cell implantation. Journal of Nuclear Medicine, 52 (SUPPL), 510.
Peer Reviewed verified by ORBi

Belle, L., Baron, F., Bruck, F., Hannon, M., SERVAIS, S., Beguin, Y., & BRIQUET, A. (2011). Despite inhibitory effects on normal hematopoiesis in vitro, Imatinib and Nilotinib do not prevent engraftment of human CD34+ HSCs in immunodeficient NSG mice. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (2011). Longitudinal Monitoring of Immune Reconstitution After Allogeneic Peripheral Blood Stem Cell Transplantation (HSCT): Impact of T Cell Depletion of the Graft. Belgian Journal of Hematology, Abstracts book (Supplement of 26th General Meeting of the Belgian Hematological Society), 31.

Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Daulne, C., Willems, E., Gothot, A., Beguin, Y., & Baron, F. (2011). Comparison of Immune Reconstitution after Non-myeloablative Hematopoietic Cell Transplantation (HCT) with Flu-TBI versus TLI-ATG Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 26th General Meeting of the Belgian Hematological Society), 8.

Humblet-Baron, S., CASTERMANS, E., Vanbellinghen, J.-F., Hannon, M., Jacobs, N., WILLEMS, E., Ormenese, S., Beguin, Y., & Baron, F. (February 2009). What Is The Role For Regulatory T-Cells After Nonmyeloablative Conditioning? Biology of Blood and Marrow Transplantation, 15 (2), 122-123. doi:10.1016/j.bbmt.2008.12.377
Peer Reviewed verified by ORBi

Castermans, E., Hannon, M., Cheynier, R., Seidel, L., Humblet-Baron, S., WILLEMS, E., Corbier, S., Gothot, A., Geenen, V., Sandmaier, B. M., Storb, R. F., Beguin, Y., & Baron, F. (2009). Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age. Blood, 114 (22), 1149.
Peer Reviewed verified by ORBi

Briquet, A., Dolhet, M., Beguin, Y., & Gothot, A. (2009). Inhibition of the Jagged-1/Notch pathway increases the hematopoiesis-supportive activity of mesenchymal stem cells. Experimental Hematology, 37 (9), 77.
Peer reviewed

Humblet-Baron, S., CASTERMANS, E., Vanbellighen, J.-F., Hannon, M., Jacobs, N., Beguin, Y., & Baron, F. (February 2008). What is the Role for Regulatory T-Cells after Nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 14 (2), 136-137. doi:10.1016/j.bbmt.2007.12.383
Peer Reviewed verified by ORBi

Briquet, A., Beguin, Y., & Gothot, A. (September 2007). The hematopoiesis-supporting activity of mesenchymal stem cells increases with the number of passages. Experimental Hematology, 35 (9, Suppl. 2), 125-125.
Peer reviewed

Briquet, A., Dolhet, M., Demeuse, J., BEGUIN, Y., & GOTHOT, A. (August 2007). Study of contribution of signalling pathways Notch, Wnt, Shh and BMP in mesenchymal stem cell prohaematopoietic activity. Acta Clinica Belgica, 62 (4), 256.
Peer Reviewed verified by ORBi

Jerusalem, G., Silvestre, R., Beguin, Y., Hustinx, R., Fassotte, M.-F., & Fillet, G. (20 June 2006). FDG-PET for the routine follow-up in NHL: First prospective evaluation. Journal of Clinical Oncology, 24 (18, Part 1 Suppl. S), 439.
Peer Reviewed verified by ORBi

Castermans, E., Baron, F., Willems, E., Meuris, N., Schaaf-Lafontaine, N., Reynier, R., Geenen, V., & Beguin, Y. (2006). Immune reconstitution after CD8-depleted or unmanipulated peripheral blood stem cells transplantation with nonmyeloablative conditioning. Acta Clinica Belgica, 61 (2), 113.
Peer Reviewed verified by ORBi

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075).
Peer Reviewed verified by ORBi

Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Hypochromic mature erythrocytes: a specific marker of iron deficiency. Acta Clinica Belgica, 58-3 (4), 325.
Peer Reviewed verified by ORBi

Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Follow-up of iron microalbuminuria in hypertensive patients: a belgian promise survey. Acta Clinica Belgica, 58-3 (4), 328.
Peer Reviewed verified by ORBi

JERUSALEM, G., BEGUIN, Y., FASSOTTE, M.-F., BELHOCINE, T., HUSTINX, R., RIGO, P., & FILLET, G. (2000). Early detection of relapse by whole-body positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) in the follow-up of patients with Hodgkin’s disease (HD). PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING 2000, 19, 10.
Peer reviewed

Oral presentations in conferences with scientific selection committee

Beguin, C., Kwan, O., Ritacco, C., Debray, J.-C., Dejardin, E., Dubois, S., Köse, M. C., Canti, L., Courtois, J., Seidel, L., Daulne, C., Caers, J., Beguin, Y., Ehx, G., & Baron, F. (17 November 2023). TNF-α priming of human regulatory T cells does not increase their ability to prevent xenogeneic graft-versus-host disease [Paper presentation]. Congrès annuel de la Société Francophone de Greffe de Moelle et Thérapie Cellulaire, Lille, France.
Peer reviewed

Kwan, O., Canti, L., Ehx, G., Beguin, Y., Humblet-Baron, S., & Baron, F. (16 November 2023). Utilisation de techniques de biologie des systèmes pour une analyse détaillée de la réponse immunitaire au vaccin à ARN messager BNT162b2 chez les patients ayant bénéficié d'une allogreffe [Paper presentation]. 26ème Congrès Annuel de l'Association Française de Cytométrie 2023, Toulouse, France.
Peer reviewed

Bodart, G., THYS, M., GANGOLF, M., CUNIN, M.-P., LAMBERT, F., POUSTOVOITOV, A., Beguin, Y., Kolh, P., & Jacques, J. (2022). Développement d’un outil de pilotage des patients oncologiques au CHU de Liège [Paper presentation]. Giseh 2022, Saint-Etienne, France.
Peer reviewed

Mina, M., Horrion Jil, SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., MALAISE, M., & MALAISE, O. (September 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Belgian Congress of Rheumatology.
Peer reviewed

Mina, M., Horrion, J., SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., Malaise, M., & MALAISE, O. (March 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Bone Curriculum Symposium 2019.
Peer reviewed

Contact ORBi